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DRUGS, AIDS AND REPRODUCTIVE CHOICE:
MATERNAL-STATE CONFLICT CONTINUES
INTO THE MILLENNIUM1
CHERYL E. AMANAt
INTRODUCTION
For more than a decade I have examined women's reproductive
rights, paying particular attention to the role of the state, if any, in a
woman's exercise of those rights. I have written and spoken about
forced obstetrical intervention, intervention with substance dependent
pregnant women, and reproductive choices of Human Immu-
nodeficiency Virus (HIV) positive women. Issues that focus on preg-
nant women are often described in terms of "Maternal-Fetal" conflict.
The tension, however, is not between a woman and her fetus, there-
fore making this description a misnomer. It would more appropriately
be described as a conflict between a woman and the state regarding
choices that she may make that the state decides may be injurious to
the developing life that she carries. For purposes of this essay, I will
refer to this conflict as "Maternal-State" conflict. State intervention
in the lives of pregnant women has become more complex as the Su-
preme Court in both Webster v. Reproductive Health Services2 and
Planned Parenthood of Southeast Pennsylvania v. Casey3 recognized a
state's compelling interest in the potential life of a fetus so long as the
woman chooses to continue her pregnancy.
1. This essay has evolved from several presentations that I have made. I have decided to
update it this year (2005) because now that Azidothymidine (AZT) has been used
therapeutically for over a decade, I wanted to review some of the more recent data on AIDS and
perinatal transmission, as well as changes, if any, in how society is responding to maternal-state
conflict as we move into the new millennium. AZT, known generically as Zidovudine, is the only
HIV drug that is fully approved for use during pregnancy. Although it is rarely used as a single
drug therapy, it is used as a monotherapy during pregnancy because it does significantly reduce
the chance of mother baby HIV transmission - see Part II of this article.
t Professor of Law, North Carolina Central University School of Law, JD-Pennsylvania;
LLM-Columbia. I would like to thank first and foremost my research assistant, Amanda Maris.
Amanda's assistance in gathering information, reminding me of deadlines and generally being
available as needed has been invaluable in completing these updates. Thanks also to Professors
Wright and Beckwith and my son and daughter-in-law Malik and Jill Morrison, who read and
gave helpful critiques of earlier versions of this article. And finally, thanks to my husband, civil
rights attorney John Burris, who has consistently lent a critical eye to my text and a critical ear to
my ideas as I worked towards finding a useful framework to address these very important issues.
2. Webster v. Reprod. Health Serv., 492 U.S. 490 (1989).
3. Planned Parenthood of Se. Pa. v. Casey, 510 U.S. 1309 (1994).
1
Amana: Drugs, AIDS and Reproductive Choice: Maternal-State Conflict Cont
Published by History and Scholarship Digital Archives, 2005
2005] DRUGS, AIDS AND REPRODUCTIVE CHOICE 33
This essay will examine the reproductive choices of HIV positive
women, particularly in light of Protocol 076, 4 the Azidothymidine
(AZT) study, the National Institute of Child Health and Development
(NICHD) study on perinatal transmission,5 as well as several studies
from developing countries. Common issues arising for the HIV posi-
tive woman include: whether she should become pregnant; if she be-
comes pregnant, whether she should carry the fetus to term or abort;
and whether her infant should be tested for Acquired Immune Defi-
ciency Syndrome (AIDS). There are also questions concerning
whether all pregnant women should be tested for AIDS and, if they
test positive, whether they should be treated with antivirals to protect
the fetus.
Protocol 076 has shown that vertical transmission of the HIV virus
from mother to child during pregnancy and shortly after birth can be
dramatically reduced by a course of treatment with Zidovudine. The
NICHD study predicts that vertical transmission can be reduced by
half if delivery is done by elective cesarean section (c-section) before
labor and prior to rupture of the membranes.6 The implications of
both studies could be far reaching and may involve "maternal-state"
conflict. How, for instance, would women who want treatment be
able to access it? Who would pay for it? Who would be informed of
their HIV status? Would the husband of the woman and/or father of
the fetus have a right to know? Would women who do not want treat-
ment or surgery be forced to accept both or either? This essay will
consider these issues and will offer a framework to assist policy mak-
ers and legal theorists as they face these and other questions relating
to "Maternal-State" conflict.
Part I of this essay provides some background of state intervention
in two contexts for pregnant women: medical care and substance de-
pendency. Recognition and support of state intervention in these con-
texts have enabled states to intervene more easily in the lives of HIV
positive women. Part II addresses AIDS generally in the African
American Community, reviewing demographic information and risk
factors for AIDS in the African American woman. Furthermore, I dis-
cuss vertical transmission of AIDS from mother to child particularly
in light of Protocol 076, the NICHD study and recent international
4. Edward M. Connor et al., Reduction of Maternal-Infant Transmission of Human Immu-
nodeficiency Virus Type 1 With Zidovudine Treatment, 331 NEW ENG. J. MED. 1173 (1994).
5. NICHD press release Jan. 1, 1999, available at http://www.niaid.nih.gov. See also, http://
www.nih.gov/news/pr/nov96/niaid-27.htm and http:l/www.niaid.nih.gov/daids/therapeutics/
researchl2002PTRA sum.htm (last visited Nov. 1, 2005).
6. The International Perinatal HIV Group, The Mode of Delivery and the Risk of Vertical
Transmission of Human Immunodeficiency Virus Type]-A; Meta-Analysis of 15 Prospective Co-
hort Studies, 340 NEw. ENG. J. MED. 977 (1999).
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studies. Part III examine- calls for mandatory testing and treatment,
and legal and ethical objections to both. Part IV concludes with rec-
ommendations for a positive, noncoercive community response to the
problem.
PART I
Recognition of a state's compelling interest in potential life and the
need for modification of state dependency statutes to incorporate the
fetus provided the groundwork for legislative and judicial intervention
in the reproductive decision-making of pregnant women. This modifi-
cation allows a state to monitor and regulate the conduct of a preg-
nant woman if it considers such intervention necessary to protect the
fetus. The state is now assisted in this regulation by the woman's phy-
sician, who at one time considered the woman as her patient, but who
now considers both the woman and the fetus as patients.7 In many
instances doctors are more than willing to place the interests of the
fetus above that of the woman.' This is particularly true if they are
dealing with women of color or women from a lower socioeconomic
class.9 Kolder & Gallagher in their study found that when court-or-
dered obstetrical intervention was sought, 81% of the women in-
volved were African American, Asian or Hispanic. In 25% of the
cases, the women did not speak English as their primary language.
Intervention was ordered in 86% of the cases and 47% of the doctors
polled said they would support forced intervention on behalf of the
fetus, including forced confinement. 10 It is apparent from the Kolder
and Gallagher study, and from other similar studies, that doctors tend
to communicate with their private white patients when conflict arises
during treatment, but are more inclined to use the courts for treat-
ment conflicts when dealing with poor patients, patients of color and/
or patients with language barriers.11
7. Cheryl E. Amana, Maternal-Fetal Conflict: A Call for Humanism and Consciousness in a
Time of Crisis, 3 COLUM. J. GENDER & L. 351, 353 (1992) (citing Jack A. Pritchard et al., Wil-
liams Textbook of Obstetrics at xi (1985)) ("Quality of life for the mother and her infant is our
most important concern. Happily we live and work in an era in which the fetus is established as
our second patient with many rights and privileges comparable to those previously achieved only
after birth.").
8. See id. citing Veronika E.B. Kolder et al., Court Ordered Obstetrical Intervention, 316
NEW ENG. J. MED. 1192, 1193-94 (1987); see also Rosa H. Kim, Reconciling Fetal/Maternal Con-
flicts, 27 IDAHO L. REV. 223, 236-37 (1991); Lawrence J. Nelson & Nancy Milliken, Compelled
Medical Treatment of Pregnant Women: Life, Liberty and Law in Conflict, 259 JAMA 1060
(1988).
9. Amana, supra note 7, at 354 (citing Nelson & Milliken, supra note 8).
10. Kolder, supra, note 8.
11. Id.; see also DOROTHY E. ROBERTS, KILLING THE BLACK BODY: RACE, REPRODUCTION
AND THE MEANING OF LIBERTY (1997) (hereafter "Killing the Black Body") (eloquently ad-
3
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The same disparate treatment seen in the use of obstetrical inter-
vention is observed with substance dependent pregnant women. For
example, Dr. Ira Chasnoff, of the National Association for Perinatal
Addiction Research and Education (NAPARE), conducted a study in
Florida showing that although the rate of illicit drug use was similar
across race and economic lines, African American women were ten
times more likely to be reported to authorities.' 2 Dr. Chasnoff also
conducted a study in North Carolina for the Department of Human
Resources, Division of Mental Health, Developmental Disabilities,
and Substance Abuse Services. This study found that although the use
of controlled substances and tobacco was roughly consistent between
African American and European American women, African Ameri-
can women were more likely to have involvement with the criminal
justice system and drug treatment programs.13 The increased treat-
ment numbers may result from the high incidence of reporting for Af-
rican American women and the likelihood that one might be diverted
to treatment once in the criminal justice system or as a condition of
probation. Moreover, it is estimated that 70 to 80 percent of women
prosecuted for prenatal drug use are Black.14 Furthermore, Professor
Dorothy E. Roberts has found that a greater percentage of African
American than European American mothers who seek prenatal care
are tested for drug use and lose custody of their children, often with-
out hearings, investigations, or any semblance of due process.15
The response to substance dependency in pregnant women has been
largely punitive rather than protective. Many states have redrafted
their abuse and neglect statutes to incorporate the fetus.' 6 In states
dressing the many dimensions of governmental regulation in the lives of African American Wo-
men when it comes to reproductive choices).
12. Ira J. Chasnoff et al., The Prevalence of Illicit Drug or Alcohol Use During Pregnancy
and Discrepancies in Mandatory Reporting in Pinellas County, Florida, 322 NEW ENG. J. MED.
1202, 1204 (1990). See also Dorothy E. Roberts, Punishing Drug Addicts Who Have Babies:
Women of Color, Equality, and the Right to Privacy, 104 HARV. L. REV. 1419 (1991). Professor
Roberts has written extensively about state intervention on reproductive choice. I have read
many of her articles in preparation for my work. She was kind enough to review my first article
in this area (see Amana, supra note 7).
13. Ira J. Chasnoff & Judith C. Burnison, Drug and Alcohol Use in Pregnancy: A Study of
Service Needs and Prevalence in the State of North Carolina (1994) (on file with the author).
14. Lynn M. Paltrow, Criminal Prosecutions Against Pregnant Women: National Update and
Overview, (ACLU/Reprod. Freedom Project) (April 1992); see also Roberts, supra note 11.
15. See Roberts, supra note 11 and Chasnoff, supra note 12.
16. See, e.g,. FLA. STAT. ANN. § 39.01(g) (West, WESTLAW through Chapter 484 and
H.J.R. No. 1 and S.J.R. No. 2394 (End) of 2004 Spec. 'A' Sess. of the Nineteenth Legislature)
(defining "harm" for purposes of proceedings relating to children including "expos[ing] a child
to a controlled substance or alcohol" where "[e]xposure to a controlled substance or alcohol is
established by [in one way ]: [1] Use by the mother of a controlled substance or alcohol during
pregnancy when the child, at birth, is demonstrably adversely affected by such usage");705 ILCS
405/702-3 (2005) (amending the Juvenile Court Act's definition of neglected or abused minor to
include "any newborn infant, whose blood or urine contains any amount of a controlled sub-
4
North Carolina Central Law Review, Vol. 28, No. 1 [2005], Art. 4
https://archives.law.nccu.edu/ncclr/vol28/iss1/4
36 NORTH CAROLINA CENTRAL LAW JOURNAL [Vol. 28:32
that have not made amendments, abuse and neglect statutes have
often been interpreted to protect the fetus.17 States have attempted to
use criminal lawr to criminalize the behavior of mothers who are preg-
nant and substance dependent. "At least 200 women, in more than 30
states, have been arrested and criminally charged for alleged drug use
or other actions during pregnancy. '18 For example, Florida, Michigan,
South Carolina and Wisconsin have each addressed this issue with va-
rying results. Prosecutors in both Florida and Michigan attempted to
use drug delivery statutes to prosecute mothers with substance abuse
problems.19 The fact that the attempted prosecutions were ultimately
stance. . with the exception of controlled substances . . .[as] the result of medical treatment
administered to the mother or the newborn infant."); IND. CODE § 31-34-1-10 (1997) (including a
child born with fetal alcohol syndrome or an addiction to a controlled substance within its defini-
tion of a child in need of services). The statute specifically provides that a child is in need of
services if it "needs care, treatment or rehabilitation that: [it] is not receiving; or [that] it is
unlikely to be provided . . .without the coercive intervention of the court." Id. See also MINN.
STAT. ANN. § 626.5561 (2) (West 1997) (defining child neglect as among other things prenatal
exposure to drugs); N.J. REV. STAT. § 30: 4C-11 (1997) (providing that "the provisions of this
section [a child endangerment statute] shall be deemed to include an application on behalf of an
unborn child ... ); N.Y. FAM. CT. LAW § 1012 (f)(I)(B) (McKinney 1979) (defining a neglected
child as "one whose physical, mental or emotional condition has been impaired ... as a result of
the failure of his parent... to exercise a minimum degree of care... in providing the child with
proper supervision or guardianship... or by misusing a drug or drugs or by misusing alcoholic
beverages"); OKAL. STAT. ANN. tit. 10, § 7001-1.3.10.a. (3) (West 1997) (including in its defini-
tion of "deprived child" one "who is a child in need of special care and treatment," which entails
"a child who at birth tests positive for alcohol or a controlled substance...").
17. See e.g., In re Ruiz, 500 N.E.2d 935, 939 (Ohio C. P. 1986) (holding that a viable fetus is
a child under its child abuse statutes); Brown v. Dept. of Health and Rehab. Services, 582 So.2d
113, 115 (Fla. Dist. Ct. App. 1991) (finding evidence of drug abuse to be a sufficient basis to
support prospective neglect); In re Stefanel Tyesha C., 556 N.Y.S.2d 280 (App. Div. 1990) (posi-
tive toxicology sufficient to support a cause of action for neglect); In re Troy D., 215 Cal.App.3d
889 (Cal. Ct. App. 1989) (allowing positive toxicology to establish juvenile court jurisdiction). Cf.
People ex rel. H., 74 P.3d 494 (Colo. App. 2003) (holding that an unborn child does not fall
within the definition of child for the purpose of a child dependency or neglect proceeding); see
also Michelle Oberman, Sex, Drugs, Pregnancy and the Law: Rethinking the Problems of Preg-
nant Women Who Use Drugs, 43 HASTINGs L.J. 505, 520-21 (1991) (recognizing that some states
such as Illinois revoke maternal custody immediately if the newborn is reported with a positive
toxicology screen); and Rorie Sherman, Keeping Babies Free of Drugs, NAT'L. L.J., Oct. 16, 1989
("In some jurisdictions women whose newborns' urine tests positive for drugs immediately lose
custody for months until they can prove to a court that they are fit mothers.").
18. Center for Reproductive Law and Policy, Punishing Women for Their Behavior During
Pregnancy: An Approach That Undermines Women's Health and Children's Interests, (CRLP
Press Sept. 2000). Women have challenged the criminal charges for drug use during pregnancy in
22 states. South Carolina has been the only state to sustain the charges. Some states that have
brought charges against pregnant women include, Arizona, California, Florida, Georgia, Indi-
ana, Kentucky, Massachusetts, Michigan, Nebraska, New Jersey, New York, Nevada, North Car-
olina, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas, Virginia, Washington, Wisconsin
and Wyoming. Id.
19. See Johnson v. State, 602 So. 2d 1288 (Fla. 1992) (concluding that the state legislature
never intended the drug trafficking laws to be used against a woman for giving birth to a drug
exposed infant); People v. Hardy, 469 N.W.2d 50 (Mich. Ct. App. 1991), appeal denied, 471
N.W.2d 619 (Mich. 1991) (rejecting the use of drug trafficking statutes to prosecute pregnant
women).
5
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unsuccessful in those instances does not mean that criminalization has
had no substantive impact. Many women charged under these stat-
utes pled guilty, thereby precluding an appeal.
20
South Carolina has been at the forefront of prosecuting women for
maternal drug use and has prosecuted the largest number of women
for prenatal drug use.21 The Supreme Court of South Carolina has
affirmed the legality of prosecuting women for maternal drug use and
the United States Supreme Court has upheld the decision. 22 Prosecu-
tors in South Carolina have vigorously enforced the existing child
abuse and neglect statutes against pregnant women addicted to crack
cocaine.
Whitner v. South Carolina involved Cornelia Whitner, a twenty-
eight-year-old woman addicted to crack cocaine, who had been prose-
cuted and sentenced to eight years in prison for fetal abuse. The
South Carolina Supreme Court reinstated Ms. Whitner's eight-year
sentence that had been vacated by the court of appeals. The court
held that a viable fetus is covered by the state child-abuse statutes.23
The court found that punishing fetal abuse furthers the state's interest
in protecting children.24 The court reasoned that "[t]he consequences
of abuse or neglect after birth often pale in comparison to those re-
sulting from abuse suffered by the viable fetus before birth,' 25 thus
recognizing the fetus as covered by the child-abuse statutes furthers
the statute's aim of preventing harm to children.
Litigation on this issue has continued. In March of 2001 the United
States Supreme Court addressed the issue of whether the Medical
University of South Carolina Hospital's (MUSC) policy of searching
pregnant women for evidence of drug use, without a warrant or con-
20. See Mother Cleared of Passing Drug to Babies, N.Y. TIMES, July 24, 1992, at B7.
21. See Lynn M. Paltrow, Criminal Prosecution Against Women: National Update and Over-
view (ACLU/Reprod. Freedom Project) (April 1992). Attorney Paltrow and the Center for Re-
productive Law and Policy have been instrumental in challenging states that seek to prosecute
women for maternal drug use. They have been particularly active in South Carolina, under-
standable given the aggressive prosecutions there, and they have compiled state by state case
summaries of criminal prosecutions against pregnant women. Attorney Paltrow has written nu-
merous articles on this issue. Likewise, Wyndi Anderson and Susan Dunn from the South Caro-
lina Advocates for Pregnant Women have consistently represented women in challenging South
Carolina's repressive policies. See also Angela L. Knutson, South Carolina Supreme Court Sends
the Wrong Message: "If You are Pregnant and Addicted Tell Your Doctor and You Will Go to
Jail": Whitner v. State, No. 24468, 1996 WL 393164 (S.C. July 15, 1996), 20 HAMLINE L. REV. 207
(1996) (giving a compelling call for a "restorative justice" approach to the problem of prenatal
substance abuse and describes in a thoughtful discussion how that approach could have worked
in South Carolina. See id. at 253-56.).
22. See Whitner v. South Carolina, 328 S.C. 1 (1997); cert. denied, May 26, 1998, Whitner v.
South Carolina, 523 U.S. 1145 (1998).
23. Id. at 1.
24. Id. at 3.
25. Id.; see also Chasnoff, supra note 12.
6
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sent, violated the Fourth Amendment's prohibition against unlawful
searches.26 Concerned about an apparent increase in the use of co-
caine in patients receiving prenatal care, a task force made up of
MUSC representatives, police and local officials developed a policy
setting out procedures for identifying and testing pregnant patients
suspected of drug use.2 7 The policy required that a chain of custody
be followed when obtaining and testing patients' urine samples; pro-
vided for education and treatment referrals for patients testing posi-
tive; and contained police procedures and criteria for arresting
patients who tested positive and prescribed prosecutions for drug of-
fenses and/or child neglect, depending on the stage of the defendant's
pregnancy.28
MUSC's policy remained in place for nearly five years. However,
instead of using the information obtained to provide medical care and
treatment, the staff provided the information to the police who then
arrested the women.2" MUSC justified the policy as one that fit within
the category of "special needs" which would allow for constitutionally
permissible suspicionless searches.30 The issue, as framed by Justice
Stevens, was "whether the interest in using the threat of criminal sanc-
tions to deter pregnant women from using cocaine can justify a depar-
ture from the general rule that an official nonconsensual search is
unconstitutional if not authorized by a valid warrant."31 The Court
concluded that "the gravity of the threat alone cannot be dispositive
of questions concerning what means law enforcement officers may
employ to pursue a given purpose. "32 The Court found that the policy
was in violation of the Fourth Amendment.3 In reaching its decision,
26. See Ferguson v. City of Charleston, 532 U.S. 67 (2001).
27. The 12 page document adopted is known as "Policy M-7" dealing with the subject of
"Management of Drug Abuse During Pregnancy."
28. Id.
29. All but one of the 30 women reported and arrested were African American. See State-
ment of South Carolina Advocates for Pregnant Women (on file with author).
30. This category described by the court as "closely guarded" was first articulated by Justice
Blackmun in a concurring opinion in New Jersey v. T.L.O., 469 U.S. 325, 351 (1985) where he
concluded that such a test would only be warranted in "those exceptional circumstances in which
special needs beyond the need for law enforcement make the warrant and probable cause re-
quirement impracticable ...." Id. The Court ultimately adopted the terminology in subsequent
cases. (See e.g. O'Connor v. Ortega, 480 U.S. 709, 720 (1987)). The Court distinguishes Ferguson
from other cases where the special needs doctrine has been applicable such as Skinner v. Rail-
way Labor Executives' Assn., 489 U.S. 602 (1989) where tests were allowed to assist the Rail-
ways in preventing accidents resulting from employees impaired by alcohol or drugs; and
Treasury Employees v. Von Raab, 489 U.S. 656 (1989) where the Customs Service was allowed
to test employees seeking promotion to identified sensitive positions.
31. Ferguson, 532 U.S. at 70.
32. Id. at 86 quoting Indianapolis v. Edmond, 531 U.S. 32, 42-43 (2000).
33. U.S. CONST. AMEND. IV ("The right of the people to be secure in their persons, houses,
papers, and effects, against unreasonable searches and seizures, shall not be violated, and no
7
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the Court concluded that the nine criteria 34 used to identify the wo-
men to be searched would not provide probable cause or a reason to
believe that they were using cocaine.
Since Ferguson v. City of Charleston, the Supreme Court of South
Carolina has addressed the issue of prenatal drug use in two related
cases-South Carolina v. Peppers36 and South Carolina v. McKnight.
37
In Peppers, Brenda Peppers was charged with violating South Caro-
lina's child endangerment statute.38 She entered a guilty plea that was
subsequently reversed by the Supreme Court of South Carolina. Pep-
pers entered the plea on the condition that she be able to appeal her
case to the South Carolina Supreme Court. The Supreme Court, in
overturning the plea, held that South Carolina did not recognize con-
ditional pleas. If an attempt is made to attach a condition to the plea,
the trial court must enter a plea of not guilty.
39
However, the Court did not address the underlying issue of the con-
stitutionality of allowing pregnant women to be prosecuted under
child abuse laws if they take drugs during pregnancy. This issue was
focused on more clearly in McKnight. Regina McKnight was con-
victed of homicide by child abuse and sentenced to twenty years in
prison. She is an indigent African American woman, with limited ed-
ucation, who had an ongoing addiction to crack cocaine. On May 15,
1999, she gave birth to a stillborn baby girl weighing five pounds.4" It
was estimated that the gestational age of the infant was between 34
and 37 weeks, and that she was viable. A subsequent autopsy showed
the presence of benzoylecgonine (a cocaine metabolite). The cause of
death was determined to be "intrauterine fetal demise with mild
chorioamnionitis, funisitis and cocaine consumption. '41 However, no
expert could say, with any degree of certainty, that cocaine was the
cause of the infant's death.
warrants shall issue, but upon probable cause, supported by oath or affirmation, and particularly
describing the place to be searched, and the persons or things to be seized").
34. The listed criteria were: No prenatal care; late prenatal care after 24 weeks gestation;
incomplete prenatal care; abruptio placentae; intrauterine fetal death; preterm labor "of no ob-
vious cause"; IGUR (intrauterine growth retardation) "of no obvious cause"; previously known
drug or alcohol abuse; and unexplained congenital anomalies. (See Policy M-7, supra note 27.).
35. Ferguson, 532 U.S. at 77, see Kolder, supra note 11.
36. South Carolina v. Peppers, 552 S.E.2d 288 (S.C. 2001).
37. South Carolina v. McKnight, 576 S.E.2d 168 (S.C. 2003); cert. denied, 540 U.S. 819
(2003).
38. S.C. CODE ANN. § 20-7-50 (Supp. 1995).
39. Peppers, 552 S.E.2d at 289 quoting State v. O'Leary, 393 S.E.2d 186, 187 (S.C. 1990).
40. McKnight, 576 S.E.2d at 171.
41. Id. Chorioamnionitis and funisitis are the terms used for the placenta and umbilical cord
when they are inflamed. Most fetuses with this condition have live births. An infant would have
benzoylecgonine in its system rather than pure cocaine because of the rapid breakdown of pure
cocaine.
8
North Carolina Central Law Review, Vol. 28, No. 1 [2005], Art. 4
https://archives.law.nccu.edu/ncclr/vol28/iss1/4
40 NORTH CAROLINA CENTRAL LAW JOURNAL [Vol. 28:32
A number of issues were raised on appeal in McKnight.42 The court
determined that there was either no error in addressing each issue or
that the issue had not been raised in the lower courts or was not pre-
served. Relying on several law journal articles,43 the court concluded
that it is incumbent on the woman to stop using drugs once a decision
has been made to carry the child to term. The court stated, "Once the
mother has made a choice to have a child, she must accept the conse-
quences of that choice. One of the consequences of having children is
that it creates certain duties and obligations to that child. If [the] wo-
man does not fulfill those obligations, then the state must step in to
prevent harm to that child."" The court's position on the equal pro-
tection claim is particularly telling. The court refused to consider this
claim concluding that it was procedurally barred and not preserved
even though Ms. McKnight had filed a pretrial motion to dismiss
based on equal protection and renewed that motion at trial.45 As Jus-
tice Moore stated in his dissent "it is for the legislature to determine
whether to penalize a pregnant woman's abuse of her own body. It is
not the business of the Court to expand the application of a criminal
statute to conduct not clearly within its ambit. To the contrary we are
constrained to strictly construe [criminal] statutes in the defendant's
favor."4 6 Nevertheless the court applied the homicide by child abuse
statute which carried a punishment of twenty years to life, rather than
the criminal abortion statute which carried a maximum penalty of two
years, and which would have been applicable had she intentionally
killed her viable fetus.
Not all states agree that a fetus is covered by child abuse statutes.
Wisconsin for example, said that a fetus is not covered. In State ex rel.
Angela M.W. v. Kruzicki,4 7 the Supreme Court of Wisconsin consid-
42. Id. Issues included whether the court erred in refusing a directed verdict on grounds
that there was insufficient evidence of the cause of death and no evidence of criminal intent or
that the baby was viable when she ingested the cocaine; whether the court erred in refusing to
dismiss the homicide by child abuse indictment on the grounds that the more specific criminal
abortion statute should govern, the statute did not apply to the facts in her case and the legisla-
ture did not intend for the statute to apply to fetuses; whether application of the homicide by
child abuse statute violated her constitutional right to privacy or her due process right of ade-
quate notice; whether the court erred in refusing to dismiss the indictment on eighth amendment
cruel and unusual punishment grounds and whether application of the homicide by child abuse
statutes violated equal protection.
43. See Marilyn L. Miller, Fetal Neglect and State Intervention: Preventing Another Attleboro
Cult Baby Death, 8 CARDOZO WOMEN'S L.J. 71 (2001); Nova D. Janssen, Fetal Rights and the
Prosecution of Women for Using Drugs During Pregnancy, 48 DRAKE L. REV. 741 (2000) and
James R. Schueller, The Use of Cocaine By Pregnant Women; Child Abuse or Choice? 25 J.
LEGISL. 163 (1999).
44. McKnight, 576 S.E.2d at 175, n. 5, relying on Janssen, supra note 43 at 762-63.
45. Id at 177.
46. Id. at 180 referencing State v. Blackmon, 403 S.E.2d 660 (S.C. 1991).
47. State ex rel. Angela M.W. v. Kruzicki, 561 N.W.2d 729 (Wis. 1997).
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ered whether the statutory definition of child included a viable fetus
for the purpose of juvenile court jurisdiction. In this case, which in-
volved a pregnant woman who tested positive for cocaine use on more
than one occasion, the trial court ordered the unborn child to be de-
tained, recognizing that "[s]uch detention will by necessity result in
the detention of the unborn child's mother. ,48 A divided court of
appeals determined that the juvenile court had not exceeded its juris-
diction.49 The state supreme court, in reversing the court of appeals,
recognized that "the essence of this case is one of statutory construc-
tion."50 The court concluded, "the legislature did not intend to include
fetus within the definition of 'child'."51 The Wisconsin Supreme Court
and other state courts that have interpreted child abuse statutes simi-
larly, appropriately recognized that the courts are not the most pro-
ductive forum for addressing the complex public policy issues inherent
in maternal drug use.52
It is apparent from the previously mentioned cases that neither the
criminal law nor the child abuse and neglect statutes provide the an-
swers to maternal drug use. Focusing only on this problem out of con-
text diverts attention from the equally harmful, if not more harmful,
effects of other variables such as the use of alcohol or tobacco or poor
diet during pregnancy. It also ignores the significant negative impact
of poverty on fetal health. Studies have shown that the harmful effects
of crack, cocaine and alcohol can be mitigated by proper prenatal care
and nutrition.53
Rather than campaigning for punitive measures against these
mothers, states should provide access to prenatal care, prevention pro-
48. Id. at 732 (quoting from the trial court record).
49. State ex rel. Angela M. W. v. Kruzicki, 197 Wis.2d 532, 541 NW.2d 482, (Wis. Ct. App.
1995).
50. State ex rel. Angela M.W. v. Kruzicki, 561 N.W.2d at 732.
51. Id. at 733.
52. Id. at 739. See also Helen A. Cole, Legal Interventions During Pregnancy: Court Or-
dered Medical Treatment and Legal Penalties for Potentially Harmful Behavior by Pregnant Wo-
men, 264 JAMA 2663 (1990). In this Trustees' Report the American Medical Association agrees
that courts are not the best forum for addressing appropriate intervention with pregnant women
on behalf of the fetus. The report indicates that "courts are ill equipped to resolve conflicts
concerning obstetrical interventions. The judicial system ordinarily requires that courts' deci-
sions be based on careful, focused deliberation and the cautious consideration of all the facts and
related concerns." Id. at 2665. Such a system cannot respond with the speed necessary given the
time constraints of pregnancy. Stare decisis does not provide the court with guidance in address-
ing these complex policy driven conflicts.
53. See, e.g., Ira J. Chasnoff et al., Cocaine/Polydrug Use In Pregnancy: Two Year Followup,
89 Pediatrics 337 (1992); Scott N. MacGregor et al., Cocaine Abuse During Pregnancy: Correla-
tion Between Prenatal Care and Perinatal Outcome, 74 Obstetrics and Gynecology 882 (1989);
Nesrin Bingol et al., The Influence of Socioeconomic Factors on the Occurrence of Fetal Alcohol
Syndrome, 6 ADVANCES IN ALCOHOL & SUBSTANCE ABUSE 105 (1987); and Bonnie Baird Wil-
ford & Jacqueline Morgan, George Washington University, Families at Risk: Analysis of State
Initiatives to Aid Drug Exposed Infants and Their Families 11 (1993).
10
North Carolina Central Law Review, Vol. 28, No. 1 [2005], Art. 4
https://archives.law.nccu.edu/ncclr/vol28/iss1/4
42 NORTH CAROLINA CENTRAL LAW JOURNAL [Vol. 28:32
grams, education and treatment. Though the need for treatment is
recognized, resources are not allocated to ensure that the need is met.
For example, in North Carolina, significant gaps in service have been
identified. More than ninety percent of substance abuse treatment
programs say they will accept pregnant women, but the services pro-
vided are extremely limited.54 Substance dependent Oregnant women
commonly identified a need for halfway houses that will accept wo-
men and children.55 These women also indicated a need for transpor-
tation, support systems and child care services.56 Similar needs for
prenatal care, prevention and treatment models are seen beyond
North Carolina.57
Coercive intervention has tremendous potential for deterring wo-
men, who are most in need, from obtaining prenatal care.58 Moreover,
there is little evidence that criminal sanctions prevent in utero drug
exposure59 or that using drugs while pregnant indicates an inability to
parent.60 The hysteria surrounding pregnant women's drug use has re-
sulted in a number of decisions that are clearly not in the child's best
interest. For example, a woman in California lost custody of her chil-
dren for three months based on a positive drug test, which resulted
54. Less than three percent of substance abuse treatment programs provide obstetric or
pediatric care; only 12 programs provide any HIV related services. Although forty-two pro-
grams state that they have residential rehabilitation services, none accept the women's children.
Children's services are limited with only five programs having day care available. Chasnoff &
Burnison, supra note 13, at 48-49. See also T. Weisdorf et al., Comparison of Pregnancy Specific
Interventions to Programs for Cocaine Addicted Women, 16 J. SUBSTANCE ABUSE TREATMENT
39 (1999) (indicating that many interventions used today were designed using male based recov-
ery models, which are not as suited to the needs of pregnant women).
55. Supra note 54.
56. Supra note 54.
57. See e.g. Wendy Chavkin & Stephen R. Kandall, Between a Rock and a Hard Place:
Perinatal Drug Abuse, 85 PEDIATRICS 223 (1990); Kary L. Moss, Forced Drug or Alcohol Treat-
ment for Pregnant or Postpartum Women: Part of the Solution or Part of the Problem? 17 NEW
ENG. J. ON CRIM. & CIv. CONFINEMENT 1 (1991) and Kary L. Moss, Substance Abuse During
Pregnancy, 13 HARV. WOMEN'S L.J. 278 (1990) (noting that liability problems created by high-
risk pregnancies and lack of obstetrical services cause many pregnant women to be excluded
from treatment centers).
58. Chavkin & Kandall supra note 57, at 224. The American Public Health Association in
an amicus brief filed on behalf of Angela Carder (In re AC, 573 A.2d 1235 (D.C. 1990)) stated
"[r]ather than protecting the health of women and children, court ordered caesareans erode the
element of trust that permits a pregnant woman to communicate to her physician -without fear
of reprisal- all information relevant to her proper diagnosis and treatment. An even more
serious consequence of court ordered intervention is that it drives women at high risk of compli-
cations during pregnancy and childbirth out of the health care system..." See supra note 17.
59. See Committee on Substance Abuse of the American Academy of Pediatrics, Drug Ex-
posed Infants, 86 PEDIATRICS 639, 641 (1990).
60. See SUSAN C. BOYD, MOTHERS AND ILLICIT DRUGS: TRANSCENDING THE MYTHS 14-16
(1999) (discussing multiple studies showing that women who use illicit drugs can be adequate
parents).
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from a sedative administered during labor. 61 There were also in-
stances in Texas and New York of children removed from their
mothers based on a single positive test for marijuana with no evidence
of harm to the children.62 While the crisis of drug exposed babies has
increased the need for residential and outpatient treatment for ad-
dicted women, the availability of such treatment remains limited.63
For example, only eleven percent of pregnant addicts obtain treat-
ment and one in four infants are born to mothers who have not re-
ceived early prenatal care.64 This number will continue to rise as
public health funding is decreased. Nine percent, or 433,000 pregnant
women at any given time, are without health insurance coverage.65
The number of children in foster care is steadily rising, child protec-
tive services are under siege, and the child welfare system is collapsing
under the weight of children reported as abused and neglected due to
allegations of drug using mothers.66
There is hope, however. North Carolina is at least attempting to
address the problem. Federal and state programs such as Healthy Ba-
bies/Healthy Start, Baby Love and WIC (Women, Infants, and Chil-
dren) are attempting outreach, education and preventive services in
61. See Woman Given Labor Sedative Loses Custody of Children, SACRAMENTO BEE, Feb.
11, 2000.
62. See LONG ISLAND MONTHLY, Jan. 1990 at 46 ; TIMES RECORD NEWS (Wichita Falls,
Texas) Nov. 11, 1999 and HOUSTON PRESS, Nov. 4, 1999 at 8.
63. See Deborah J. Krauss, Pregnant Cocaine Addicts Facing Harsher Sentences in the
Courts, N.Y.L.J., May 1, 1992, at S-10; see also Wendy Chavkin, Help Don't Jail Addicted
Mothers, N.Y. TIMES, July 1989 at A21; Wendy Chavkin, Mandatory Treatment for Drug Use
During Pregnancy, 266 JAMA 1556 (1991) and Elaine W. v. Joint Diseases N. Gen. Hosp. Inc.,
613 N.E.2d 523, 524 (N.Y.) (illustrating a New York Hospital's refusal to admit pregnant women
into its drug detoxification program).
64. See NATIONAL COMMISSION ON CHILDREN, BEYOND RHETORIC: A NEW AMERICAN
AGENDA FOR CHILDREN AND FAMILIES 119, 123 (1991) [hereinafter BEYOND RHETORIC]. It
should be noted that although the number of drug infected newborns increased more than 300%
between 1979 and 1987, drug use among child-bearing age women has been reported to be
slowly declining from 15% in 1985 to 8% in 1990. (See American Academy of Pediatrics, Com-
mittee on Drugs report, Neonatal Drug Withdrawal, 101 PEDIATRICS 1079, n.6 (June, 1998)).
65. BEYOND RHETORIC, supra note 64, at 137.
66. This is apparent anecdotally to anyone who is involved in the child welfare system. For
example, in Durham, N.C. prevention monies were jettisoned from the social services budget
several years ago. In Philadelphia, Pa. where I have practiced, the outlook is equally poor with
insufficient resources and burgeoning caseloads. See also Barry M. Lester et al., Keeping Mothers
and Their Infants Together: Barriers and Solutions, 22 N.Y.U. REV. L. & Soc. CHANGE 425
(1996). The author notes that between 1983 and 1992 the number of children in foster care
increased from 269,000 to 442,000. Id. at 435. He suggests that given the state of the foster care
system, foster care may prove more detrimental to drug exposed children than remaining with
their mothers. Id. at 433-35. Child abuse and neglect reports more than doubled in the 1980s,
from 1.15 million in 1980, to 2.4 million in 1989. From June 1987 to June 1990, foster care cases
increased by 29% (from 280,000 to 360,000). Id. Federal law requires periodic review (usually at
least every six months) for each child in foster care. See THE ADOPTION ASSISTANCE AND CHILD
WELFARE ACT OF 1980: THE FIRST TEN YEARS 58-59 (North American Council on Adoptable
Children, ed. 1990).
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community settings and several states have model programs. 67 Educa-
tion should be initiated prior to a woman's childbearing years and
continued throughout. There must be consistent support for these pro-
grams to be continued and replicated. The outcome will be worth the
effort for both pregnant women and society.68
PART II
Many of the issues affecting substance dependent women also im-
pact HIV positive women. These populations overlap considerably
because those most at risk for HIV are intravenous drug users, prosti-
tutes (who are often drug dependent) and partners of intravenous
drug users (who may also have a history of drug use). 69 Ninety-three
percent of HIV positive women are of childbearing age (between 13
and 49).70 Eighty percent of reported cases of HIV positive women
are women of color.7' In 1999, HIV infection was the third leading
cause of death among African American women aged twenty-five to
forty-four. It became the leading cause of death among African
American women aged twenty-five to thirty-four in 2001.72 HIV in-
67. See L.R. Metsch et al., Implementation of a Family-Centered Treatment Program for
Substance-abusing Women and Their Children: Barriers and Resolutions, 27(1) J. PSYCHOACTIVE
DRUGS 73 (1995) (describing an eighteen month residential treatment program in Florida); S.
Burman, A Model for Women's Alcohol/Drug Treatment, 9(2) ALCOHOLISM TREATMENT
QRTLY. 87 (1992) (describing an intensive outpatient treatment program in Illinois that has
treatment staff and child welfare professionals working collaboratively); Amy Goldstein, Fresh
Start and a New Life: State Funded Center Melds Drug Treatment, Prenatal Care to Help Recover-
ing Addicts and Their Babies, WASH. POST, June 11, 1992 at Ml. (describing a successful model
in Baltimore, Md. that combines treatment, prenatal care and child care) and Kathleen Teltsch,
In Detroit, a Drug Recovery Center That Welcomes the Pregnant Addict, N.Y. TIMES, Mar. 20,
1990, at A14 (describing a successful program in Detroit, Michigan).
68. For each dollar spent on providing prenatal care to low-income, poorly educated wo-
men, society saves three dollars and twenty eight cents in medical care for the infants of these
women in the first year of life. David Chavkin, "For Their Own Good:" Civil Commitment of
Alcohol and Drug Dependent Pregnant Women, 37 S.D.L. REV. 224, 245 & n.136 (1992) (quoting
Ira J. Chasnoff, Drugs, Alcohol, Pregnancy, and the Neonate: Pay Now or Pay Later, 266 JAMA
1568, 1568 (1991) and sources cited therein).
69. See A. Alyce Werdel, Mandatory AIDS Testing: The Legal, Ethical and Practical Issues,
5 NOTRE DAME J.L. ETHICS & PUB. POL'Y 155, 165-69 (1990).
70. See Centers for Disease Control and Prevention, HIV/AIDS update: A Glance at the
HIV Epidemic (2000) at http:www.cdc.gov/hiv (Dec. 2000).
71. Centers for Disease Control and Prevention, Status of Perinatal HIV Prevention: U.S.
Declines Continue (1999) (relying on 1998 statistics that identify Aftican American and Hispanic
women as eighty percent of reported AIDS cases) available at http://www.cdc.gov/hiv/pubs/facts/
perinatl.pdf (Nov. 1999).
72. Centers for Disease Control and Prevention, H!V/AIDS Among African Americans
(citing excerpts from the 2003 National Vital Statistics Reports, 52(9) National Vital Statistics
Reports 1, 27-33 (2003) available at http://www.cdc.gov/nchs/data/nvsr/nvsr52/nvsr5209.pdf).
See also, Centers for Disease Control and Prevention, Young People at Risk: HIVIAIDS Among
America's Youth, at http://www.cdc.gov/hiv; Robert N. Anderson et. al., Deaths: Leading Causes
for 2001, 52(9) National Vital Statistics Reports 27-33 (2003) available at http://www.cdc.gov/
nchs/data/nvsr/nvsr52/nvsr52_09.pdf.
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fection was among the top four causes of death for African-American
women aged twenty to fifty-four in 2001."3 From 2000 to 2003 the
HIV/AIDS rate of infection for African American females was
nineteen times the rate of White females and five times the rate for
Hispanic females.7 4 Moreover, AIDS is now the sixth leading cause of
death among fifteen to twenty-four-year-olds. 7 5 The proportion of to-
tal AIDS cases attributable to women is increasing. From 1985
through 1996, the proportion of women reported to the Centers for
Disease Control and Prevention (CDC) with AIDS increased from
seven percent to twenty percent.76 The total number of female AIDS
cases attributable to heterosexual contact is also increasing. In 1994,
AIDS cases in women attributable to transmission via heterosexual
contact surpassed the number attributable to transmission via intrave-
nous drug use.77 This is particularly troubling when one considers that
although African American women are most likely to become in-
fected as a result of sex with men, many are unaware of their male
partners' risks for HIV infection.78 Even though new HIV infections
have declined from a peak in the mid-1980's of more than 150,000 to
approximately 40,000 annually in the 1990s, poor African American
women are still at great risk for infection based on a number of fac-
tors. For example a recent study of African American women in
North Carolina found that women with HIV infection are more likely
than non-infected women to be unemployed, to receive public assis-
tance, to have a life time history of genital herpes infections, to have
73. Supra note 72.
74. Centers for Disease Control and Prevention, Diagnoses of HIV/AIDS-32 States, 2000-
2003, 53(47) MMWR 1106-10 (2004) available at http://www.cdc.gov/mmwr/preview/mmwrhtml/
mm5347a3.htm (Nov. 1, 2005). Furthermore, the rate of AIDS diagnoses for African American
women was 25 times the rate for White women. See Centers for Disease Control and Preven-
tion, Cases of HIV Infection and AIDS in the United States, 2003, 15 HIV/AIDS Surveillance
Report 1-46 (2005) available at http://www.cdc.gov/hiv/stats/2003surveillancereport.htm.
75. CDC Report Shows Drop in Sexual Risk Behaviors Among U.S. Teens, INFECrIous Dis-
EASES IN CHILDREN, at 88 (Oct. 1998) (noting that although the number of sexually experienced
teenagers dropped from 54.1% in 1991 to 48.4% in 1997, there are still too many youth at risk -
nearly half of all HIV infections in the United States occur among young people under 26).
76. Id.
77. Id. See also Centers for Disease Control and Prevention, Cases of HIV Infection and
AIDS in the United States, 2003, supra note 74.
78. Such male risks include unprotected sex with multiple partners, bisexual behavior, and/
or injection drug use. In a recent study of HIV infected and non-infected African American men
who have sex with men (MSM), approximately 20% of the study participants reported having
had sex with a female in the preceding six months. Centers for Disease Control and Prevention.
HIV Transmission Among Black College Student and Non-student Men Who Have Sex with Men
- North Carolina, 2003, 53(32) MMWR 731-34 (2004) available at http://www.cdc.gov/mmwr/
preview/mmwrhtml/mm5332al.htm. Equally telling is a study showing that of HIV infected per-
sons, thirty-four percent of African American MSM reported having sex with women, even
though only 6% of African American women reported having sex with a bisexual man. (See JP
Montgomery et al. The Extent of Bisexual Behavior in HIV-infected Men and Implications for
Transmission to their Female Sex Partners, 15(6) AIDS Care 829-37 (2003).
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more than twenty lifetime sexual partners, to have used crack or co-
caine, or to have traded sex for drugs, money or shelter.79 We are
indeed concerned with a very fragile population of women.
Consistent with the increased number of HIV positive women of
childbearing age, there is an increased number of pediatric AIDS
cases.80 The majority of these children are HIV positive because of
"vertical transmission" in which the virus passes from mother to fetus
before or during birth. Vertical transmission can occur during gesta-
tion, during delivery or from breast-feeding.8 1 When twins are born,
the first born is likely to be infected. Absent medical intervention,
vertical transmission rates are fairly consistent at twenty-five to thirty
percent.82 As a result, seventy to seventy-five percent of infants born
to positive mothers will not be infected. It is currently not possible to
determine whether a fetus is infected with the virus prior to birth. It
also is not clear how many infants who test positive at birth will ser-
oconvert to negative once their immune systems have developed and
their mothers' antibodies are no longer in their systems.83 For infants
who do not seroconvert, the disease will progress much more quickly
than in adults. According to early CDC data, children diagnosed with
AIDS lived a median of nine months' and seventy percent died
within two years.85
79. Centers for Disease Control and Prevention, HIV Transmission Among Black Women-
North Carolina, 2004, 54(4) MMWR 89-93 (2005), available at http://www.cdc.gov/mmwr/pre
view/mmwrhtml/mm5404a2.htm.
80. From 1993 to 1994 the number of pediatric AIDS cases increased by 8%. At the end of
1994 a total of 6209 pediatric AIDS cases were reported to the Centers for Disease Control and
Prevention. Id. AIDS is currently the fifth leading cause of death among children under the age
of 15 in the United States. Id.
81. Pamela J. Boyer et al., Factors Predictive of Maternal-Fetal Transmission of HiV-1. Pre-
liminary Analysis of Zidovudine Given During Pregnancy and/or Delivery, 271(24) JAMA 1925
(1994). According to the Centers for Disease Control and Prevention, 91% of all AIDS cases
reported among U.S. children result from mother to child transmission, either during pregnancy,
labor and delivery or by breast feeding. Centers for Disease Control and Prevention, Status of
Perinatal HIV Prevention: U.S. Declines Continue (2005) at http://www.cdc.gov/hiv/pubs/facts/
perinatl.htm. Reduction in perinatal transmission based on zidovudine (AZT) therapy continues
to be striking. For example, the Centers for Disease Control and Prevention's Perinatal AIDS
Collaborative Transmission Study (PACTS) shows that AZT use has contributed to a drop in
perinatal transmission from 21% to 11%. The PACTS study included women from four urban
cities-New York City, Newark, Baltimore and Atlanta.
82. Connor, supra note 4, at 1173.
83. While all infants born to an HIV positive woman will test positive as a result of the
mother's antibodies seventy to seventy-five percent of the babies will seroconvert to negative
within fifteen to eighteen months after birth. John Modlin & Alfred Sabb, Public Health and
Clinical Aspects of HIV Infection in Women and Children in the United States, in AIDS, Women
and the Next Generation (Ruth R. Faden et al. eds. 1991).
84. Id.
85. Michael A. Grizzi, Recent Developments: Compelled Antiviral Treatment of HIV Positive
Pregnant Women, 5 UCLA WOMEN'S L.J. 473, 480-81 (1995).
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More recent studies seem to indicate that infants who have acquired
HIV perinatally follow one of two patterns: Rapid Disease Progres-
sion (RPD), which occurs in ten to thirty percent of infected infants,
and Non-Rapid Disease Progression (NRPD), occurring in seventy to
ninety percent of infants.86 Infants with RPD experience an impair-
ment of immunologic depletion within the first few months of life. On
the other hand, those infants with NRPD experience gradual impair-
ment of immunologic function over a number of years and a disease
progression more like that of infected adults.87 Infants who are ex-
posed to Zidovudine perinatally are significantly more likely to ex-
hibit RPD.88 Children generally are not included in clinical trials
though, and it is unclear how some of the success with antivirals and
protease inhibitors will impact the progression of their disease. As
would be expected, given the incidence of AIDS in African American
and Hispanic women, studies have shown that children of color are
disproportionately affected. Of the 382 cases reported with AIDS in
1998, 84 percent were African American or Hispanic children. 89 To-
gether, these two demographics make up only thirty percent of chil-
dren under thirteen in the United States.9"
In 1994 the National Institutes of Health (NIH) conducted the
AIDS clinical trial Protocol 076 which studied 477 HIV positive preg-
nant women in their fourteenth to thirty-fourth weeks of pregnancy.9'
Half of the women were randomly assigned to a treatment arm where
they received AZT during the last two trimesters of their pregnancies
and intravenously during labor and delivery. The other half received
placebos. The infants were treated for six weeks after birth. Neither
the women nor the researchers knew which women were receiving
AZT and which were receiving placebos. During the trial period, 409
women gave birth to 415 infants. Some infants were excluded from the
results because their HIV status was not known at the time the data
was analyzed or because treatment was not started due to neonatal
death or withdrawal from the study.92 Of the 363 infants whose HIV
86. Ricardo S. de Souza et al., Effect of Prenatal Zidovudine on Disease Progression in
Perinatally HIV-1-Infected Infants, 24 J. ACOUIRED IMMUNE DEFICIENCY SYNDROMES 154
(2000)
87. Id.
88. Id. at 157. This increased risk is another consideration when considering intervention
with ZDV.
89. See CDC Status report, supra note 81.
90. M.F. Rogers, Epidemiology of HIV/AIDS in Women and Children in the USA, 86
ACTA PAEDIATRICA 15 (supp. 421 1997).
91. Connor, supra note 4.
92. Id.
16
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status was known, 25.5 percent of the placebo group were HIV posi-
tive, while 8.3 percent of the AZT group tested positive.93
In the NICHD study, the largest, most comprehensive analysis of its
kind, researchers found that HIV positive pregnant women could re-
duce the risk of transmitting the virus to their infants by elective c-
section, if performed before labor and before their membranes rup-
tured. The study included 8,533 mother and child pairs from five Eu-
ropean and ten North American studies. Mothers participating in the
study were divided into four groups: those who had elective c-sections;
those who had c-sections after rupture of their membranes and/or af-
ter labor began; those who delivered vaginally with assistance from
forceps or vacuum suction; and those who delivered vaginally with
neither forceps nor vacuum suction.
After adjustment for receipt of antiretroviral therapy, maternal
stages of the disease and infant birth weight, the likelihood of vertical
transmission decreased by approximately 50 percent with elective c-
section as compared with other methods of delivery.94 With both elec-
tive c-section and antiretroviral therapy during prenatal, interpartum,
and neonatal periods, the likelihood of transmission was reduced by
approximately 87 percent as compared with other methods of delivery
and the absence of therapy. 95 Two more recent studies have shown
compelling evidence that the prime risk factor for transmitting the vi-
rus perinatally is the mother's viral load. This was confirmed by the
Pediatric AIDS Clinical Trials Group (PACTG) study. Researchers
measured HIV levels in stored blood samples from HIV infected wo-
men enrolled in PACTG 185, a study which was stopped early, but
that compared the effectiveness of AZT alone versus AZT plus im-
mune globulin containing HIV-1 antibodies.96
As a result of the remarkable reduction in transmission with AZT
treatment, bills were introduced in Congress and in some state legisla-
tures calling for mandatory testing of pregnant women and for
unblinding of seroprevalence tests conducted on infants in forty-five
93. Id.
94. See International Perinatal HIV Group, supra note 6. Elective cesarean section is de-
fined as cesarean section before rupture of the membranes and before the beginning of labor. Id.
95. Supra note 94.
96. Lynne Mofenson et al., Risk Factors for Perinatal Transmission of Human Immu-
nodeficiency Virus Type 1 in Women Treated With Zidovudine, 341 NEW ENG. J. MED. 385-93
(1999); The second article with similar findings was by Patricia M. Garcia et al., Maternal Levels
of Plasma Human Immunodeficiency Virus Type 1 RNA and the Risk of Perinatal Transmission,
34 NEW ENG. J. MED. 394-402 (1999). Other risk factors include: Mother's low CD4 count; her
water breaks at least four hours before delivery; she has a vaginal delivery; a difficult labor
requiring episiotomy or forceps; mother has a genital infection such as Chlamydia; illicit drug use
during pregnancy. See http://www.aidsmap.com/en/docs/8766F941-6A4C-4F13-B5BE-A936138D
4546.asp (last visited Nov., 1, 2005).
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states.97 There was some apprehension among health care profession-
als with this response. Given the very real stigmatization and discrim-
ination that results from a positive HIV status, most professionals
recognized that testing would have to be conducted with appropriate
care and caution. 98 In July of 1995, the Centers for Disease Control
recommended routine, voluntary testing of all pregnant women.99 As
the calls for testing were made, some understanding of testing policy
was required. Mandatory is not the same as routine testing, and vol-
untary testing may not be routine. The CDC's recommendation of
voluntary testing for all women verges on being mandatory. Routine
testing usually requires little communication and counseling, while
voluntary testing may involve some counseling. 100 Routine testing will
probably not work for HIV. It is not like other sexually transmitted
diseases. There is no cure and there is still a valid concern with dis-
crimination."' 1 It also may result in differing responses from the medi-
97. See Centers for Disease Control National AIDS Clearinghouse (testing conducted in all
states other than Idaho, Nebraska, North Dakota, South Dakota and Vermont and conducted in
Puerto Rico, the Virgin Islands and the District of Columbia).
98. Carol B. Barnett, The Forgotten and Neglected: Pregnant Women and Women of
Childbearing Age in the Context of the AIDS Epidemic, 23 GOLDEN GATE U. L. REV. 863 (1993).
99. The 1996 amendment to the Ryan White Care Act, codified at 42 U.S.C. § 300ff-33,
requires the States to adopt the guidelines issued by the Centers for Disease Control and Pre-
vention concerning recommendations for human immunodeficiency virus counseling and volun-
tary testing for pregnant women. It became effective October 20, 2000. A New York Assembly
Bill (AB 6747) requiring that the anonymous seroprevalence test performed on newborns be un-
blinded and parents notified of the result was defeated in the July 1994 Legislative session. The
author of AB 6747, Assemblywoman Nettie Mayersohn of Albany, N.Y., was not deterred by
the bill's defeat. She introduced a new bill (AB 6684-B) in the 1995-96 session that would in-
clude HIV testing as one of the routine tests performed on newborns and that would provide for
mandatory counseling and voluntary HIV testing for pregnant women (this bill was referred to
the Assembly's Health Care Committee, where it died in committee). See Lenardo Renna, New
York State's Proposal to Unblind HIV Testing for Newborns: A Necessary Step in Addressing a
Critical Problem, 60 BROOK. L. REV. 407 (1994).
100. All Things Considered: "Voluntary AIDS Testing for Pregnant Women Urged by
CDC" (NPR radio broadcast, Feb. 22, 1995).
101. Linda Farber Post, Unblinded Mandatory HIV Screening of Newborns: Care or Coer-
cion?, 16 CARDOZO L. REV. 169, 227 n.67 (1994). The American Civil Liberties Union (ACLU)
reported on several studies documenting such discrimination: (1) In a survey of more than 500
dentists, 63% did not want to treat patients considered at risk for AIDS; (2) Another study of
1000 surgeons showed that 90% endorsed a policy of refusing to operate on a person who is HIV
positive; (3) In a Virginia study of paramedics 40% said they were unwilling to administer treat-
ment to HIV positive patients; (4) In a study of nursing home administrators, 47% said they
would refuse to accept a patient with AIDS; (5) In a study of hospitals, 20% reported that in at
least one instance a staff member refused to care for an HIV infected person and 25% had a
policy of immediately transferring any such patient. (ACLU/AIDS Project, N.Y., N.Y. 1990 "Ep-
idemic of Fear" at 31, 78-80) (on file with the author). See Winifred J. Pinch, Caregivers' Perspec-
tives on Confidentiality for Mothers and Newborns With HIVIAIDS, 4 PEDIATRIC AIDS AND
HIV INFECtrION: FETUS TO ADOLESCENT 123 (1993). The questionnaire results recording fre-
quencies of discrimination against women with HIV showed the following:
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cal community. 10 2 HIV testing historically has required both pre and
post-test counseling.103 If a move to routine testing is considered, a
review of genetic testing, including sickle cell testing, might prove
instructive.
As genetic testing has become more readily available, concern
about privacy and discrimination has increased.104 Genetic testing has
been shown to affect one's relationship with insurers, employers and
other third parties. Accordingly, people have been deterred from be-
ing tested because of a fear of consequences. 10 5 Such beliefs may be
well founded where studies show that 31 percent of families with a
known genetic condition were denied insurance whether they were
sick or not.10 6 There has also been an instance where a normal healthy
Type of Discrimination % Often % Sometimes % Never
Employment 34 63 3
Housing 26 69 5
Physical Abuse 13 76 11
Psychological Abuse 36 61 3
Rejection by Families 35 65
Rejection by Friends 37 63
Rejection by Neighbors, Coworkers 39 62
And Others
102. Supra note 101.
103. See Mike Mckee, Testing HIV Policy, RECORDER, May 17, 1995, at 1.
104. See Juliet J. McKenna, Where Ignorance is Not Bliss: A Proposal for Mandatory HIV
Testing of Pregnant Women, 7 STAN. L. & POL'v REV. 133, 137 (1996). Ms. McKenna's article is
well written and although we start out with some of the same premises and same sources, we end
up with slightly different positions. I cannot agree with her call for mandatory testing of all
pregnant women and I do not think my disagreement is one of semantics. She calls for
mandatory testing but not mandatory treatment. Although I recognize that the constitutional
issues between testing and treatment may be heightened, the moral issues are implicated in both.
It would seem to me that mandatory, non-directive counseling would reach the same results that
she suggests and address her concern that only poor and minority women would be tested absent
a mandatory scheme. See Larry Gostin, Genetic Discrimination: The Use of Genetically Based
Diagnostic and Prognostic Tests by Employers and Insurers, 17 AM. J.L. & MED. 109 (1991); See
also Lori B. Andrews, Prenatal Screening and the Culture of Motherhood, 47 HASTINGS L.J. 967
(1996). Professor Andrews has written extensively in the area of reproductive rights and societal
control of women during pregnancy.
105. Caryn Lerman et al., Interest in Genetic Testing Among First-degree Relatives of Breast
Cancer Patients, 57 AM. J. MED. GENETICS 385, 389 (1995). Caryn Lerman cites a 1995 Harris
poll that found 86% of people were concerned that employers and insurers would use the results
of genetic tests in hiring and insurance decisions. In one study of women's interest in genetic
testing for breast cancer, 15% of women declined testing because they worried about losing their
insurance. According to Senator Olympia Snowe, who introduced a genetic privacy bill in the
Senate this year (2005), when the National Institutes of Health offered women genetic testing for
breast cancer risk, nearly 32% of those receiving the offer refused to be tested because of con-
cerns about insurance discrimination. See infra note 113.
106. See COMMITTEE ON ASSESSING GENETIC RISKS, NATIONAL ACADEMY OF SCIENCES, As-
SESSING GENETIC RISKS: IMPLICATIONS FOR HEALTH AND SOCIAL POLICY at 270 (Lori B. An-
drews et al. eds. 1994).
19
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child who had been diagnosed with Phenylketonuria (PKU)' °7 at birth
and successfully treated, was denied coverage under her father's
group health plan when he changed jobs,10 8 and where women with a
family history of breast cancer have been told they could be insured
but not for breast cancer treatment.1"9 Dr. Herbert Nickens has been
especially concerned about the implications of genetic testing for Afri-
can Americans. He has called genetics "a science of inequality" that
"entwines society's racial, ethnic and economic biases with genetic dif-
ferences that can be detected, particularly if any of these differences
are differentially distributed by race, ethnicity or class."' 10
Similar discrimination has occurred in employment. In the early
1970's, as routine sickle cell testing became common, employers' dis-
crimination against African American employees and job applicants
who were carriers of the disease increased, despite the fact that carrier
status has no impact on one's health or job performance."1 ' In 1995,
the San Francisco Legal Services Office filed a class action suit against
the federally funded Lawrence Berkeley Laboratories at the Univer-
sity of California-Berkeley. The suit alleged that the laboratory tested
African American employees for sickle cell without their knowledge
or consent and secretly maintained the testing results in its files.
112
Also of concern, but beyond the scope of this paper is whether infor-
mation gleaned from genetic testing should be shared with family
members.
107. Id. This genetic condition affects one's ability to process phenaylalanine, an amino acid
commonly found in most proteins. Left untreated the disease causes severe mental retardation.
Retardation can be avoided by modifying the mother's diet during pregnancy and raising the
child until age four on a diet low in phenaylalanine.
108. See Paul R. Billings et al., Discrimination as a Consequence of Genetic Testing, 50 AM. J.
HUM. GENETICS 476 (1992).
109. Id. at 478; See also Julie Holland, Should Parents Be Permitted to Authorize Genetic
Testing for Their Children?, 31 FAM. L.Q. 321 (1997) (describing a number of types of discrimi-
nation associated with genetic disorders).
110. Herbert Nickens, The Genome Project and Health Services for Minority Populations, in
THE HUMAN GENOME PROJECT AND THE FUTURE OF HEALTH CARE (Thomas Murray et al.
eds., 1996) (describing Genetics as sometimes a "racialized science" where stereotypes, and bi-
ases may frame its interpretation, management and use).
111. Id. There are a number of comprehensive articles on genetic testing and some of the
legal and ethical concerns associated with testing. In addition to Dr. Nickens' article, I would
recommend Deborah Gridley, Genetic Testing Under the ADA: A Case For Protection From
Employment Discrimination, 89 GEO. L.J. 973 (2001); and Mark A. Rothstein, Employee Selec-
tion Based on Susceptibility to Occupational Illness, 81 MICH. L. REV. 1379 (1983).
112. Norman-Bloodsaw v. Lawrence Berkely Nat'l Lab., No. C95-03220 V.R. Walker, J.
(N.D. Cal.1995) The court for the Northern District of California ruled in favor of the defendant
and the plaintiff appealed (Ct. of App. No. 96-16526 (1996)). The appeal was heard in 1997,
Norman-Bloodsaw v. Lawrence Berkeley Nat'l Lab., 135 F.3d 1260 (9th cir. 1998), and an agree-
ment was finally reached between the class of plaintiffs represented by the suit and the lab in
2001 (2001 WL 764473 (N.D. Cal. 2001)). Samples were not only tested for sickle cell but were
also tested for syphilis and pregnancy.
20
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AIDS testing has as much a potential for abuse and discrimination
as genetic testing. As protocols for testing are developed, they must
be undertaken with the same concerns for confidentiality and protec-
tion against abuse. The concern with abusive use of genetic informa-
tion is reflected in numerous attempts by state and federal legislatures
to enact legislation to deal with the issue. The most recent attempt at
the federal level was in February of 2005 when the United States Sen-
ate approved without opposition the Genetic Information Nondis-
crimination Act.1 13 At the state level 41 states have passed health
insurance laws and 31 states have passed workplace laws in an attempt
to limit discrimination and misuse of genetic information. 114 Some
state legislation is more comprehensive than others. The Americans
with Disabilities Act (ADA) of 1990 provides some protection from
discrimination that is based on a disability or perceived disability. Ad-
ditionally, while in office President Clinton signed an executive order
prohibiting genetic discrimination. 115 Because of the unevenness in
protection provided from state to state and the lack of any protection
in some states, a federal statute is warranted. Even then companies
with fourteen or fewer employees would be exempted.
PART III
If a woman is HIV positive and AZT/antiviral treatment is consid-
ered, her cooperation will be vital for her treatment to be successful.
Similarly, if a c-section is indicated she would have to consent to such
surgery. Care must be taken to ensure that those most in need of
treatment are not driven underground and that they receive the treat-
ment without coercion. 6 With careful counseling, mandatory testing
and treatment should be unnecessary. As initial surveys of hospitals
that have instituted voluntary testing found, properly counseled preg-
nant women agree to testing ninety-six percent of the time. 1 7
Given the ability to significantly reduce vertical transmission with
antiviral treatment, it would seem logical to argue for mandatory test-
113. See S. 306, 109th Cong. (2005) (passed Senate February 17, 2005). It still must pass in
the House, and that is by no means assured. A similar bill passed by a 95-0 vote in 2004 to no
avail because it was never taken up by the House.
114. See THE HUMAN GENOME PROJECT: EXPLORING OUR MOLECULAR SELVES; see also
THE STATE OF LEGISLATION-WHAT'S PROTECTING Us? available at the North Carolina Center
for Genomes and Public Health.
115. Exec. Order No. 13, 145, 65 Fed. Reg. 6877 (February 8, 2000).
116. See Cole, supra note 52.
117. See McKee, supra note 103. Later studies have indicated that of 90% of women offered
AZT prophylaxis 90% were compliant. See Universal Testing, Counseling Critical to Reducing
Perinatal H1V Infection, INFECTIOUS DISEASES IN CHILDREN, Feb. 1999; but cf Andrew A.
Wiznia et al., Zidovudine Use to Reduce Perinatal HIV Type I Transmission in an Urban Medical
Center, 275 JAMA 1504 (1996) asserting that 25% of HIV positive pregnant women refused
treatment and of those who agreed to treatment 33% were noncompliant. Id.at 1505.
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ing and treatment. However, when one considers what such treat-
ment would entail, it is apparent that mandatory treatment would not
be feasible unless one were willing to confine a woman for the dura-
tion of her pregnancy.118 It is important to note that treatment would
require the mother to take the medicine five times a day, every day,
during the last two trimesters of her pregnancy, and would require
that she receive the drug intravenously during labor and delivery. She
would also have to give it to her newborn for six weeks postnatally 1 9
Even if the testing is voluntary, the consent would have to be
informed. 1
20
Informed consent assumes that an individual should be free to exer-
cise her free will when making important decisions concerning her
medical treatment and care. The doctrine of informed consent as re-
ceived from the common law required that consent to health care be
voluntary, knowing and competent. Constitutional support for in-
formed consent was recognized by the Supreme Court in Cruzan v.
Director, Missoui Department of Health.1 2' The court held "the no-
tion of bodily integrity has been embodied in the requirement that
118. See Paltrow, supra note 21.
119. See Connor, supra note 4.
120. The following states have enacted statutes that require informed consent prior to con-
ducting an HIV antibody test: ALA. CODE SEC. 22-11A-51 (1991 & Supp. 1996); ARIz. REV.
STAT. ANN. § 36-663 (West, WESTLAW through the 2nd Reg. and 2nd Spec. Sess.'s of the Forty-
Sixth Legislature 2004); CAL. INS. CODE § 799.03 (West, WESTLAW through Ch. 1 of 2005
Reg.Sess.); CoLo. REV. STAT. § 25-4-1401 (West, WESTLAW through the end of the 2004 2nd
Reg. Sess. of the 64th General Assembly); CONN. GEN. STAT. ANN. § 19a-582 (West,
WESTLAW through Gen. St., Rev. to 1-1-05); DEL. CODE ANN. tit. 16 § 1202 (1995); D.C. CODE
ANN. § 31-1606 (West, WESTLAW through November 29, 2004); FLA. STAT. ANN. § 381.004
(West 1993 & Supp. 1997); HAW. REV. STAT. § 325-16 (West, WESTLAW through 2003 Reg. and
Spec. Sess.'s); ILL. STAT. ANN. Ch. 410 305/4 7304 (West's Smith-Hurd, WESTLAW through
P.A. 93-1084 of the 2004 Reg. Sess.); IND. CODE ANN. § 16-41-6-1 (West, WESTLAW through
2005 Public Laws approved and effective through February 8, 2005); IOWA CODE ANN. § 141A.6
(West, WESTLAW through laws effective July 1, 2004); Ky. REV. STAT. ANN. § 214.625 (West,
WESTLAW through end of 2004 First Extraordinary Sess.); LA. REV. STAT. ANN. § 40:1300.13
(West 1992 & Supp. 1997); ME. REV. STAT. ANN. tit. 5 § 19203-A (West 1989 & Supp. 1996); MD.
CODE ANN., Health-Gen. I § 18-336(b)(1) (1989); MASS. GEN. LAWS ANN. Ch. 111, § 70F (West
1992); MICH. CoMP. LAWS ANN. § 333.5133(2) (West Supp. 1991); MINN. STAT. ANN. § 144.7407
(West, WESTLAW Current with 2005 Reg. Sess. laws through Ch. 2); Miss. CODE ANN. § 41-41-
16 (1993); MONT. CODE ANN. § 50-16-1007 (1995); N.H. REV. STAT. ANN. § 141-F:5 (1993); N.M.
STAT. ANN. § 24-2B-2 (Michie 1996); N.Y. PuB. HEALTH LAW § 2781 (McKinney 1996); N.C.
GEN. STAT. § 130A-148(h) (West, WESTLAW through the 2004 Reg. and Extra Sess.'s); N.D.
CENT. CODE23-07.5-01, -02 (1991 & Supp. 1995); OHIO REV. CODE ANN. § 3701.242 (Baldwin
Supp. 1995); OR. REV. STAT. §§ 433.045, 433.075 (1995); PA. STAT. ANN. tit. 35 § 7605 (a),
§ 7606, 7608 (supp. 1993); R.I. GEN. LAWS § 23-6-12 (1996); TEX. HEALTH & SAFETY CODE
ANN. § 81.105 (West 1992); VT. STAT. ANN. tit. 18, § 1128(a) (1996); VA. CODE ANN. § 32.1-37.2
(Michie 1992 & Supp. 1996); WASH. REV. CODE. ANN. § 70.24.325 (West, WESTLAW through
Chapter 2 of 2005 Regular Sess.); W. VA. CODE§ 16-3C-2 (1995); Wis. STAT. ANN.§ 252.15
(West, WESTLAW through 2003 Act 327, published 6/11/04).
121. Cruzan v. Dir., Mo. Dept. of Health, 497 U.S. 261 (1990).
22
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informed consent is generally required for medical treatment.1' 22 The
Centers for Disease Control has recognized the importance of in-
formed consent in its recommendations for voluntary testing. Included
in the recommendations are the following:
Pretest counseling should be linguistically, culturally and education-
ally appropriate;
Counseling should be done as early in pregnancy as possible so that
informed therapeutic and reproductive decisions can be made in a
timely fashion;
Post-test counseling should take into account the woman's psychologi-
cal needs, social support structures and risk of discrimination and do-
mestic violence and doctors should make referrals to psychological,
social or legal services if the need arises;
Uninfected pregnant women who continue to have unprotected sex or
use injection drugs should be encouraged to avoid further HIV expo-
sure and be retested in the third trimester of the pregnancy to rule out
recently acquired HIV infection;
Physicians should explain the possible benefits and possible risks of
AZT therapy in a nonjudgmental manner and let patients make their
own decisions;
HIV positive women should get information on all reproductive op-
tions, but without coercion;
Doctors should evaluate a woman's need for anti-microbial drugs to
ward off infections;
HIV positive women should be advised against breast feeding and
support services should be enlisted to find breast milk substitutes for
infant feeding;
Health care providers should keep track of the needs of infected wo-
men and children and make referrals to medical and social services as
needed.
123
Providing the information necessary for a woman to make an in-
formed decision encourages her to participate in her medical care. By
exchanging information, asking questions and indicating specific is-
122. Id. at 270. The court stated that "a constitutionally protected liberty interest in refusing
unwarranted medical treatment could be inferred" from its prior decisions.) Other courts have
recognized the doctrine. See, e.g., United States v. Williams, 754 F.2d 672, 674 (6th Cir. 1985)
(defining informed consent as "unequivocal, specific and intelligently given, uncontaminated by
any duress or coercion").
123. Recommendations (supported by the CDC) of the U.S. Public Health Service on the
Use of Ziovudine to Reduce Perinatal Transmission of the Human Immunodeficiency Virus. See
also supra note 99; 42 U.S.C. § 300ff-33 (additional guidelines promulgated by the CDC).
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sues of concern, the patient is permitted to acknowledge her own au-
tonomy and to make choices consistent with her belief system. 124
The same concerns presented when considering mandatory treat-
ment with AZT are also present with the use of elective c-section to
reduce vertical transmission of the virus. The woman ultimately must
consent to treatment if it is to occur. And she will have every right to
refuse treatment after she is provided with all the relevant informa-
tion. Ensuring that a woman's consent is truly voluntary and informed
will require skill on the part of health professionals. They will have to
recognize that poor people and women generally have been more will-
ing to let doctors make decisions for them believing that the doctors
"know best. ' 12 5  Until women's relationships with their doctors
change, there will be a disparate power relationship that will hinder
true consent.
Even if an argument could be made for mandatory testing, the same
argument would have to be stretched to support mandatory treat-
ment.126 In addition to the concerns discussed above with informed
consent, mandatory treatment must be considered in light of a wo-
man's right to privacy, liberty and bodily integrity. Treatment,
whether in the form of medicine or surgery, must comport with sub-
stantive due process protections. People do not lose their rights sim-
ply because they become pregnant or HIV positive. Competent adults
have the right to refuse medical treatment even if the refusal would
result in their deaths.127
The right to physical liberty and bodily integrity implicated in medi-
cal treatment decisions has been recognized and protected by our
courts for more than a century.12 8 In Union P. R. Co. v. Botsford, the
Court said "[N]o right is held more sacred, or more carefully guarded
under the common law than is the right of every individual to the
possession and control of his own person ... 29 That right has re-
124. Doctors Faden and Beauchamp describe this approach to structuring medical decision-
making in their book. RUTH FADEN & TOM BEUCHAMP, A HISTORY AND THEORY OF IN-
FORMED CONSENT (1986). Lori Andrews also addresses this issue in her article: Lori Andrews,
Informed Consent Statutes and the Decisionmaking Process,5 J. LEGAL MED. 163 (1984).
125. See e.g. Lisa Napoli, The Doctrine of Informed Consent and Women: The Achievement
of Equal Value and Equal Exercise of Autonomy, 4 AM. U. J. GENDER & LAW 335 (1996) and
Nsiah-Jefferson, Reproductive Laws, Women of Color, and Low Income Women, 11 WOMEN'S
RTS. L. REP. 15 (1989) Professor Nsiah-Jefferson points out that women, regardless of color or
education level are less likely then men to question the doctor's orders. She cites to Martha
Eliot's Health Center, Reproductive Health Report (1985) which discusses the impact of the
classism and racism of health care providers.
126. See McKenna, supra, note 104.
127. See Schloendorff v. Society of N.Y. Hosps., 105 N.E. 92, 93 (N.Y. 1914) ("Every human
being of adult years and sound mind has a right to determine what shall be done with his own
body...").
128. Union P. R. Co. v. Botsford, 141 U.S. 250 (1891).
129. Id. at 251.
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ceived consistent recognition and protection by the Supreme Court
and state courts in a number of cases since Botsford.130 The right is
broad based, applying to prisoners as well as patients involuntarily
committed to mental institutions. 131 The right is protected by the
Fourteenth Amendment's guarantee of due process and the Fourth
Amendment's prohibition against unreasonable search and seizure.1 32
A competent adult has the right to refuse treatment and cannot be
forced to submit to treatment for the benefit of a third person, even if
treatment involves little pain or inconvenience and even if the third
person is one's own child. For instance, a mother is not legally re-
quired to donate a kidney if her child needs it; nor would an identical
twin be forced to donate bone marrow to a sibling in need. a33 Courts
have found generally that society is not diminished by the refusal to
compel an individual to submit to medical intervention for the benefit
of another.
130. See, e.g., Cruzan v. Director of Mo. Dep't of Health, 497 U.S. 261 (1990); Bouvia v.
Superior Court, 225 Cal. Rptr. 297 (Cal. Ct. App. 1986); Superintendent of Belchertown v.
Saikewicz, 370 N.E.2d 417 (Mass. 1977); In re Conroy, 486 A.2d 1209 (N.J. 1989); In re Quinlan,
355 A.2d. 647 (N.J. 1976), cert. denied, 429 U.S. 291 (1976). For more recent treatment see also In
re Guardianship of Schiavo, 780 So. 2d 176 (Fla. Dist. Ct. App. 2001). This controversial case,
involving termination of life prolonging procedures for a patient in a persistent vegetative state
and without an advance directive, spanned thirteen years and all three branches of government
at both the state and federal level. It returned to the Florida Court of Appeals twice in 2001
alone. See also Bush v. Schiavo, 851 So.2d 182 (Fla. App. 2003) (Schiavo IV); Bush v. Schiavo,
861 So. 2d 506 (Fla. App. 2003); and Bush v. Schiavo, 866 So. 2d 136 (Fla. App. 2004).
131. Washington v. Harper, 494 U.S. 210 (1990) (holding that a prison inmate has a liberty
interest, under the due process clause, in refusing to take anti-psychotic drugs); Mills v. Rogers,
457 U.S. 291 (1982); Youngberg v. Romeo, 457 U.S. 307 (1982) (finding that the due process
clause creates a liberty interest in involuntarily committed patients to be free from unreasonable
bodily restraints.).
132. See Winston v. Lee, 470 U.S. 753 (1985) (forcing a criminal to undergo surgery to re-
cover bullet as evidence violates the Fourth Amendment); Rochin v. California, 342 U.S. 165
(1952) (pumping the stomachs of criminal suspects constitutes an unreasonable search under the
fourth amendment) but cf, Schmerber v. California, 384 U.S. 757 (1966) (forcing an accident
victim to submit to blood test to determine blood alcohol level not violative of Fourth Amend-
ment prohibition against unreasonable search and seizure) and Skinner v. Railway Labor Execu-
tives' Ass'n, 489 U.S. 602 (1989) (finding as reasonable under the Fourth Amendment a drug test
of railroad workers - the government's compelling interest in safety outweighs the worker's in-
terest in privacy).
133. W. PAGE KEETON ET AL., PROSSER AND KEETON ON THE LAW OF TORTS § 56, at 375
(5th ed. 1984) (indicating that even in cases of special relationships there is no obligation to
render aid where to do so would endanger one's self); see also McFall v. Shimp, 10 Pa. D. & C.3d
90 (1978) (Alleghany County Court 1978) (refusing to compel a man to donate bone marrow to
his terminally ill cousin even though he was the only compatible donor. The court questioned
whether the cousin's decision was morally sound but recognized there was no legal duty). But cf
Hart v. Brown, 289 A.2d 386 (Conn. Supp. Ct. 1972) (permitting the parents of a seven year old
to consent to a kidney transplant to save the life of her twin sister) and Little v. Little, 576
S.W.2d 493 (Tex. Civ. App. San Antonio 1979) (permitting a mother-guardian of a fourteen year
old with Down's Syndrome to consent to the removal of a kidney from her daughter's body to be
transplanted into the body of her son who was suffering from end stage renal disease).
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There are arguments for and against treating a pregnant woman dif-
ferently when it comes to treatment decisions. A woman should not
be treated differently based on her pregnancy, but that does not mean
that she will not be. 34 Some courts have authorized performance of c-
sections and interuterine blood transfusions over the pregnant wo-
man's objection, holding that such intervention was necessary to pre-
serve the life or health of the fetus. 135 These cases provide significant
precedent for physicians who would argue for elective c-sections with
all HIV positive pregnant women, whether they choose such treat-
ment or not.
Some states automatically invalidate or limit the enforceability of
advance directives such as living wills if the patient is pregnant.
136
Some argue that a pregnant woman who continues her pregnancy has
a moral obligation to submit to treatment on behalf of her fetus.'37 As
with McFall v. Shimp, it is difficult to change the questionable moral
obligation into a legal one. 1 38
One's interest in refusing medical treatment is not absolute, how-
ever. We have seen in the cases discussed above some instances
134. See Lawrence J. Nelson et al., Forced Medical Treatment of Pregnant Women: "Compel-
ling Each to Live as Seems Good to the Rest," 37 HASTINGS L.J. 703 (1986).
135. See, e.g., Jefferson v. Griffin Spalding County Hosp. Auth., 274 S.E.2d 457 (Ga. 1981).
The Georgia Supreme Court affirmed a juvenile court opinion ordering a woman to undergo a
Cesarean section. The woman was in her thirty-ninth week of pregnancy, and she was diagnosed
with placenta previa. The operation was ordered to save the life of both the mother and child.
Mrs. Jefferson, who refused to consent to the operation for religious reasons, seemed to have her
prayers answered. Although the doctors said "there is a 99 to 100 percent certainty that the
unborn child will die if she attempts a vaginal delivery," she delivered a healthy baby vaginally.
See also Around the Nation: Pregnant Woman Believes Prayers Obviated Cesarean, N.Y. TIMES,
Jan. 26, 1981, at A12; In re Jamaica Hosp., 491 N.Y.S.2d 898 (Sup. Ct. 1985) (ordering a blood
transfusion to a woman in her eighteenth week of pregnancy who objected to the transfusion for
religious reasons and holding that the state's interest in the not yet viable fetus outweighed the
patient's interest.); but cf. Taft v. Taft, 446 N.E.2d 395 (Mass. 1983) (vacating an order requiring
a woman in her fourth month of pregnancy to undergo a "purse string" operation to prevent
miscarriage. The court found no compelling circumstances to outweigh the women's religious
objections and her privacy interest.) See also supra notes 8-10 and accompanying text.
136. See, e.g., The Uniform Rights of the Terminally Ill Act § 6(c) (1989) which reads "Life
sustaining treatment must not be withheld or withdrawn pursuant to a declaration from an indi-
vidual known by the physician to be pregnant... so long as it is probable that the fetus will
develop to the point of live birth with continued application of life sustaining treatment." See
also MINN. STAT. ANN. § 145B.13 (West 1997) (providing "in the case of a living will of a patient
that the attending physician knows is pregnant, the living will must not be given effect as long as
it is possible that the fetus could develop to the point of live birth with continued application of
life-sustaining treatment").
137. John A. Robertson, Procreative Liberty and the Control of Conception, Pregnancy and
Child Birth, 69 VA. L. REV. 405 (1983); Margery Shaw, Conditional Prospective Rights of the
Fetus, 5 J. LEGAL MED. 63 (1984). Professor Shaw has argued for policies to prevent the birth of
children with genetic diseases, suggesting that the prevention of genetic disease is so important
that parents who decide to give birth to a child with a serious genetic disorder should be crimi-
nally liable for child abuse. See also supra note 43, articles cited and accompanying text.
138. See supra note 133; see also Susan Goldberg, Medical Choices During Pregnancy: Whose
Decision is it Anyway? 41 RUTGERS L. REV. 591 (1989).
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where a state has intervened. The state has an interest in intervening
to preserve life, prevent suicide, protect the integrity of the medical
profession and to protect innocent third parties.139 State intervention
is warranted when the state's interest outweighs the individual's inter-
est in being free from intrusion. 140 Some factors the court will con-
sider in balancing the interests include: the relationship between the
intervention sought and the state interest set forth to justify it;
whether the intervention is necessary to protect innocent third parties;
whether the intervention benefits the individual; and whether there
are less restrictive alternatives to protect the state's interest and to
accommodate the rights of the individual.1 41 As mentioned above, the
Supreme Court has recognized a compelling state interest in the po-
tential life of the fetus throughout the pregnancy.1 42 But the Supreme
Court also has said the fetus is not a person under the Fourteenth
Amendment of the Constitution.143
As such, protecting the fetus as an innocent third party could be
problematic. A state attempting to compel treatment using its parens
patriae 144 powers and basing it on the best interest of the child would
have to view the fetus as a child for this purpose. In doing this, the
state will encounter the same issues that were raised in Part I when
considering whether the fetus is a child under the abuse and neglect
statutes. Even if a state gets over that hurdle and considers the fetus
an innocent third party, it must acknowledge that intervention cannot
occur without actively involving the pregnant woman. She has a con-
stitutionally protected liberty interest in her own body and in rejecting
treatment, and at least one court has upheld the right of a HIV in-
fected mother to refuse treatment for her HIV infected son. If a
mother can refuse treatment for a living child, she surely should be
able to refuse it on behalf of an unborn child. 45
139. See Grizzi supra note 85, at 488; see also Superintendent of Belchertown v. Saikewicz,
370 N.E.2d 417 (Mass. 1977).
140. See Skinner, 489 U.S. 602 (1989), Cruzan v. Dir., Mo. Dep't of Health, 497 U.S. 261
(1990) (finding the patient's right to refuse treatment must be balanced against the state's inter-
est in protecting life); Jacobson v. Massachusetts, 197 U.S. 11 (1905) (holding that the individ-
ual's right to refuse a vaccination must be balanced against the state's interest in public health).
141. See Carol Gosain, Protective Custody for Fetuses: A Solution to the Problem of Maternal
Drug Use? Casenote on Wisconsin ex. rel. Angela v. Kruzicki, 5 GEo. MASON L. REV. 799 (1997).
142. See supra notes 2 & 3.
143. Roe v. Wade, 410 U.S. 113 (1973).
144. See 67A C.J.S. Parens Patriae §195 (1978). ("The doctrine of parens patriae expresses
the inherent power and authority of the state to provide protection of the person and property of
a person non sui juris, and under the doctrine the state has sovereign power of guardianship over
persons of disability.").
145. See In re Nikolas E., 720 A.2d 562, 566 (Me. 1998) (holding that the mother's decision
to delay drug therapy was rational and reasoned). The court further reasoned that "with the
relative uncertainty of the efficacy of the proposed treatment, it can only reasonably be left up to
the parent to make an informed choice in this regard." Id. at 566.
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It is too soon to tell if treatment with AZT will preserve life and
protect the fetus. We know that it impacts the vertical transmission
rates, but we still do not know about long term effects. Preliminary
data question whether administering it to a woman before it is medi-
cally indicated will jeopardize her health if she develops an antiviral
resistant virus, thus limiting her treatment options.'46 Additional trials
are also necessary to determine the most effective time period and
duration for treatment. Must it start at fourteen weeks or could it start
later? 47 Is the IV infusion necessary during labor and delivery?
Would that alone be effective? Is the treatment for six weeks
postnatally useful?' 48 Without treatment, a fetus has a seventy-five
percent chance of being HIV negative. There is limited data on
whether the HIV negative infant will suffer any effects from the in-
trauterine exposure.' 4 9 Treatment will not cure the underlying disease
in either the mother or the child who remains HIV positive.
It is still unclear whether the findings from Protocol 076 will be use-
ful with a different population of HIV positive women. The women in
this study were asymptomatic. Their CD4 T-lymphocyte counts were
146. See Grizzy, supra note 85, at 492.
147. Very preliminary studies with two to four years of additional data indicate: between 3.2
& 6.1 percent rate of transmission if treatment is begun prenatally; between 10 & 10.7 percent if
treatment is given in the intrapartum period; between 9.3 & 12.5 percent if treatment is begun
within the first 48 hours of life and between 18.4% & 42.9% with treatment begun 3 to 42 days
after birth. See Nancy A. Wade et al., Abbreviated Regimens of Zidovudine Prophylaxis and
Perinatal Transmission of the Human Immunodeficiency Virus, 339 N. ENG. J. MED. 1409 (Oct.
1998) and Susan Fiscus et al., Trends in HIV Counseling, Testing, and Antiretroviral Treatment of
Human Immunodeficiency Virus-Infected Women and Perinatal Transmission in North Carolina,
JOURNAL OF INFECTIOUS DISEASES, 180:99-105 (1999).
148. Some more recent studies suggest that a shorter regimen may be more feasible in reduc-
ing mother-to-child transmission in developing countries. It is currently possible to reduce trans-
mission by 66% with treatment throughout pregnancy at a cost of roughly $1,000 or by 51%
beginning at 36 weeks gestation at a cost of $50. See Short Course of AZT Reduces Rate of
Perinatal HIV Transmission, INFECTIOUS DISEASES IN CHILDREN, Mar. 1999 at 24. Another issue
that arises is what intervention, if any, there should be with HIV positive mothers, who breast
feed, in developing countries. It is currently estimated that 5% of infants born to mothers with
HIV who live in developing countries become seropositive through postnatal breast-feeding.
Transmission rates appear to be related to the length of time the infant is breast-fed. There are
still unanswered questions about whether the infants could be latently infected with the virus,
with the infection surfacing during breast-feeding. See Infants Born to HIV Positive Mothers at
Greater Risk to Become Seropositive, INFECTIOUS DISEASES IN CHILDREN, Oct. 1998 at 80.
149. Early data is uncertain. There have been early reports that there is no risk at least for
cancer. (See Zidovudine, Cancer Link not Found in Treated Infants, INFECTIOUS DISEASES IN
CHILDREN, Feb. 1999); There have also been reports of some danger. See Mitchell L. Zoler,
Vertical Transmission of Multidrug-Resistent HIV, PEDIATRIC NEWS, at 23 Mar. 1999 (indicating
that a neonate whose mother had received treatment during pregnancy appeared to inherit a
viral strain resistant to two different classes of anti-HIV drugs and within a few months devel-
oped a strain that was resistant to a third class of drugs). The article further reported that 2 of
203 infants born to HIV infected mothers who received combined treatment with zidovudine
and lamivudine during pregnancy developed a rare, fatal complication called mitrochondrial dys-
function. It should be noted that with the neonate who became multi-drug resistant, the mother
had a history of treatment and noncompliance with several types of anti-HIV drugs. Id.
28
North Carolina Central Law Review, Vol. 28, No. 1 [2005], Art. 4
https://archives.law.nccu.edu/ncclr/vol28/iss1/4
60 NORTH CAROLINA CENTRAL LAW JOURNAL [Vol. 28:32
relatively high (forty-one percent had counts between 200 and 500,
and fifty-nine percent had counts over 500). None had undergone
previous antiretroviral treatment. 150 Physicians have also found that
AZT treatment can cause some "severe toxic side effects."' 15' What
we do know is that treatment outcomes have improved markedly in
the past few years. The so called "AIDS cocktail" which uses combi-
nation antiretroviral therapy shows real promise in depressing viral
loads and extending life that has some quality to it. Being treated at a
medical facility with experience in AIDS treatment is critical. For ex-
ample one study of 887 women covered under Medicaid showed that
seventy-one percent of those treated at high volume treatment facili-
ties were alive twenty-one months after diagnosis, while only fifty-one
percent had the same results if treated at a facility with less experi-
ence. 152 Generally the outlook for women who are HIV positive is
good, but even with improved therapies they are fifteen times more
likely to die within a six year period than women who are HIV
negative. 15 3
There are also unresolved issues associated with elective c-sections.
For example, some data indicate that the risk of complications in HIV
positive women may be higher than in negative women. 54 Moreover,
cesarean delivery, both non-elective as well as elective, is associated
with significant morbidity in infected women. 155 Even though the ini-
tial reports on the protective effect of elective c-sections are promis-
ing, the choice to undergo this surgery, given the risk to the HIV
positive women, must be their own. The decision should be made by
the woman in consultation with her treating physician. State interven-
tion would be ill advised. The decline in perinatal transmission with-
out state intervention has been remarkable. Reported cases
decreased in children younger than one year by 79 percent and in chil-
dren between one and five years by 67 percent in the years from 1993
150. Deborah H. Pinkney, AZT Found to Reduce Perinatal HIV Transmission Risk, 37 AM.
MED. NEws 4 (1994) (preliminary results from studies currently being conducted of women with
lower CD4 counts seem to indicate the transmission rates may still be lowered). See Boyer, supra
note 81.
151. See Martha A. Field, Pregnancy and AIDS, 52 MD. L. REv. 402 (1993). This article cites
a New England Journal of Medicine study that found AZT treatment related side effects include
nausea, headaches, myalgas and anemia. Id. at 427.
152. See JOURNAL AIDS (March 1998); see also http://www.aegis.comnews/re/1998/RE980
303.html (last visited Nov. 15, 2005).
153. Id.
154. Lynn M. Mofenson, Can We Eradicate Perinatal HIV Transmission in the US?, presented
at 6th Conference on Retroviruses and Opportunistic Infections, Jan. 1999; see also abstract from
Dr. Jennifer S. Read, National Institute of Child Health and Human Development (on file with
author); and infra note 169.
155. Supra note 154.
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to 1997.156 We certainly do not need to do anything coercive which
could result in noncompliance and failure to seek treatment.
Some states have enacted criminal statutes to allow prosecution of
those who engage in conduct that creates a risk of transmission.15 7
Without clarification it is foreseeable that some states may attempt to
use these statutes against pregnant women who refuse treatment and
who have HIV positive children just as they attempted to use drug
delivery statutes and criminal child abuse statutes against pregnant
women who bear children with positive drug toxicologies. 158 We are
already seeing calls for civil commitment.' 59 Will an HIV positive
child be able to sue her parents? 16
0
We have also begun to see further state intervention in the lives of
HIV positive women, even after the birth of the child. In Eugene,
Oregon, a juvenile court judge has prohibited an HIV positive woman
from breast feeding her infant son.1 ' The State intervened within
hours after the birth of the child after a doctor expressed concern
about the mother breast-feeding the baby. The family remained
under regular supervision of the state, which retained legal custody of
the child. A social worker visited the home weekly to ensure that the
baby was bottle fed. 62 Interestingly, the attorney for the mother in
156. Id.
157. See e.g. GA. STAT. § 16-5-60 (West, WESTLAW through 2005 Special Sess.); Miss.
STAT. tit. XII, Chapt. 191 § 191.677: ILL. COMP. Chapt. 720, § 5/12-16.2 (yr.) and INN. ANN.
CODE tit. 35, art. 38 § 35-36.1-7.1.
158. See supra notes 11-25 and accompanying text.
159. In the context of substance abuse, see e.g. Mara Lynn Krongard, A Population at Risk:
Civil Commitment of Substance Abusers After Kansas v. Hendricks, 90 CAL. L. REV. 111 (2002).
160. In California proposition 64 was placed on the ballot in 1986. The proposition, which
was defeated, would have required public officials to quarantine anyone who was HIV positive
and would have forbidden anyone with AIDS from teaching or attending public school. See
Martha A. Field, Testing for AIDS: Uses and Abuses, 16 AM. J.L. & MED. 34 (1990). One exam-
ple of potential state intervention into the lives of pregnant HIV women was North Carolina
Senator Jesse Helms advocacy for quarantine as a means of controlling the spread of AIDS. See
also Sandra Anderson Garcia & Ingo Keilitz, Involuntary Civil Commitment of Drug- Dependent
Persons with Special Reference to Pregnant Women, 15 MENTAL & PHYSICAL DISABILITY L. REP.
418. (1991). This article reports that twenty-four states and the District of Columbia have specific
detailed provisions for involuntary commitment of drug dependent persons and eleven have
limited provisions. Fifteen have no specific provisions, but eleven of that group would allow
commitment under their general commitment statutes. There also have been suggestions that a
child should be able to bring a wrongful life action against a physician or medical professional
for failure to test and disclose to a pregnant woman that she is HIV positive. See John F. Her-
nandez, Perinatal Transmission of HIV: Cause for the Resurrection of Wrongful Life, 27 J. MAR-
SHALL L. REV. 393 (1994). Wrongful life actions are not favored in most jurisdictions and there is
no reason to believe it would be viewed anymore favorably in the case of AIDS.
161. See HIV-Infected Mother Can Keep Baby but Must Bottle-Feed, SEATTLE TIMES, Apr.
21, 1999 at B8.
162. Id; See also Robin Power Morris, The Corneau Case, Furthering Trends of Fetal Rights
and Religious Freedom. 28 NEW ENG. J. ON CRIM. & Civ. CONFINEMENT 89 (2002) (detailing a
case in which a pregnant woman, Rebecca Corneau, was held in custody until she gave birth
because she was refusing prenatal care). During a previous pregnancy Ms. Corneau's child, Jer-
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this case also represented the mother in In re Nikolas E.163 There are
currently several studies to assess the HIV transmission rate in the
breast-feeding period.1 64 Most are being conducted in developing
countries where the majority of infants are breast fed. If a strong cor-
relation is established, will we be facing anti-breast feeding police who
monitor the homes of HIV positive mothers to ensure that their in-
fants are bottle-fed? As unappealing as that would be, the Oregon
case clearly indicates that it is not far fetched. And, what alternatives
do we offer women in developing countries without the resources and
support for bottle feeding? The issue of AIDS in developing countries
is of continuing concern. The future is not particularly bright. Most
new cases of HIV infection in children occurs in developing countries.
Nearly ninety percent of all HIV infected babies are born in Africa.
UN AIDS estimates that there were 1.4 million children worldwide
under age fifteen and living with HIV/AIDS at the end of 2000. Of
these children, almost all acquired the virus from their mothers,
before or during birth or during breast feeding. 165 Clinical trials are
being conducted in developing countries, but certainly not on the
same level as in the United States and other more developed coun-
tries. Because of the lack of infrastructure to support clinical trials and
research, researchers have had to be more innovative. In Uganda, for
instance, a clinical trial reported a marked reduction in mother to
child transmission with a single dose of nevirapine. 166 Three phase III
randomized placebo controlled trials using short course AZT regimes
were conducted in Thailand and the Ivory Coast. The estimated trans-
mission rate was 9.4 percent at two and six months compared with
18.9 percent in the placebo arm.167 A similar trial in a breast feeding
emiah, died at birth from what authorities believe was a lack of adequate medical care. She was
refusing medical care during pregnancy because she belonged to a cult that shunned science and
medicine as a form of blasphemy. She was held in protective custody until her baby was born on
October 16, 2000. See David Abel, Pregnant Sect Member in State Custody, BOSTON GLOBE,
Sept. 1, 2000 at Al.
163. See supra note 145.
164. See, Joseph Saba, abstract S7, The results of the PETRA Intervention Trial to Prevent
Perinatal Transmission in sub-Saharan Africa, Address at the Sixth Conference on Retroviruses
and Opportunistic Infections in Chicago, Illinois, (Jan. 31 - Feb. 4, 1999); see also Andrea Ruff,
abstract S8, Breastfeeding Correlates of Transmission and Prevention, Address at the Sixth Con-
ference on Retroviruses and Opportunistic Infections in Chicago, Illinois, (January 31 - February
4, 1999).
165. See http://www.unaids.org/en/Resources/epidemiology/epicore.asp (last visited Nov. 1,
2005).
166. See http://www.unaids.org.
167. N. Shaffer, R. Chuachoowong, P.A. Mock, et al., Short-course Zidovudine for Perinatal
HJV-1 Transmission in Bangkok, Thailand: A Randomised Controlled Trial, 353 LANCET 773
(1999); S.Z.Wiktor, E. Ekpini, J.M. Karon, et al., Short Course Oral Zidovudine for Prevention of
Mother-to-Child Transmission of HIV-1 in Abidjan, C6te d'lvoire: A Randomised Trial, 353 LAN-
CET 781 (1999); and F. Dabis, P. Msellati, N. Meda, et al. Six-month Efficacy, Tolerance, and
Acceptability of a Short Regimen of Oral Zidovudine to Reduce Vertical Transmission of HIV in
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population in the Ivory Coast was conducted by the Ivory Coast gov-
ernment and the CDC. 168 These successful trials provide some hope
for developing countries where the ACTG 076 regimen is neither af-
fordable nor feasible.
We know that transmission rates can be reduced significantly using
delivery by c-section. Again the lack of adequate resources for the
procedure as well as the increased risk of infection would have to be
addressed. Studies to date have shown that cesarean births in devel-
oping countries have a relatively high risk of post operative mortality.
There is also a concern with complications which are increasingly
common among HIV positive women, particularly if they have a se-
verely suppressed immune system. 169 The special challenges in devel-
oping countries must be considered as we craft a response to HIV
infection among the poorest of the poor.
There is an ongoing concern among public health professionals and
some members of the legal community that doctors and states may
attempt to restrict an HIV positive woman's reproductive choice by
encouraging that she abort if pregnant, or be sterilized if she is not. 170
It is conceivable that a woman would choose to abort to avoid prose-
cution under the criminal statutes mentioned above. It is also conceiv-
able that a state concerned with the cost of foster care and health care
for these infants would encourage abortion, sterilization or contracep-
tion for HIV positive women. Some still view an HIV positive wo-
man's decision to become pregnant or to continue her pregnancy as
being selfish, or to categorize her as a bad mother. The sentiment is
that no HIV positive woman would voluntarily get pregnant. Surely
she would not want her child to be born with AIDS or be orphaned.
Racism exacerbates the lack of respect for the reproductive choices of
HIV positive women, of poor women, and of African-American wo-
men generally.171
During the last decade, as the availability of long term birth control
has become common, and as it has become possible to sterilize a wo-
man on an outpatient basis, we have seen a significant increase in
Breastfed Children in C6te d'lvoire and Burkina Faso: A Double-blind Placebo-controlled Mul-
ticentre Trial, 353 LANCET 786 (1999).
168. Id.
169. M. Bulterys, A. Chao, A. Dushimimana, et al., Fatal Complications After Cesarean Sec-
tion in HIV Infected Women, 10(8) AIDS 923 (1996).
170. See infra note 171; see supra note 137.
171. See Roberts, supra note 11; supra notes 8-12. See also Dorothy E. Roberts, Unshackling
Black Motherhood, 95 MICH. L. REV. 938 (1997) and Taunya L. Banks, Reproduction and
Parenting, IN AIDS LAW TODAY 216 (Scott Burris et al. eds., 1993). See also Walker v. Pierce,
560 F.2d 609 (4th Cir. 1977), cert. denied, 434 U.S. 1075 (1978). Dr. Pierce's practice of sterilizing
Medicaid patients after the birth of their third child was upheld as his publicly and freely an-
nounced policy. This was so even though the policy was based on economic factors rather than
on the health of the mother.
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courts ordering women to be sterilized, to practice contraception or to
otherwise limit their reproductive capacity. 172 It is not difficult to en-
vision judges who feel that an HIV positive woman's choice to have a
child is socially irresponsible and morally reprehensible, and should
therefore be controlled. We should reject this "Good mom-Bad mom"
construct. HIV positive women and poor women of color who be-
come pregnant and choose to continue the pregnancy are vilified, yet
society seems invested in creating and preserving genetic ties between
caucasian parents and their children. Time and again, we see limits
placed on African-American women when it comes to procreative
choice.1 73 The choices of both women should be respected. We would
not encourage a pregnant woman with a terminal disease to abort, nor
would we require a woman who is carrying a child with a potentially
fatal or crippling genetic condition to do SO. 1 74 Why should we feel or
reason differently if the woman is HIV positive? With proper treat-
ment there is a good prognosis for an HIV positive woman to have a
number of healthy years before the onset of symptoms and society is
searching feverishly for a cure.175 "Knowing that her own prognosis is
bad, or even anticipating a short life expectancy, may provide a very
strong reason for a woman to seek fulfillment in motherhood. 1 76 The
greater chance is that a child born to an HIV positive woman would
not be HIV positive. A three out of four chance for a "normal" child
may sound like good odds to women who may be poor, minority, and
who have probably not been dealt the best hand in life.
172. See generally Stacey L. Arthur, The Norplant Prescription: Birth, Women Control or
Crime Control? 40 UCLA L. REV. 1 (1992). See also Roberts, 95 MICH. L. REV. 938 and
Catherine E. McCanna, Note, A Hot Debate in the Summer of 2001: State v. Oakley's Excessive
Intrusion on Procreative Rights, 36 IND. L. REV. 857 (2003). State v. Oakley involved David
Oakley, a father of nine, who failed to meet his child support obligations. At trial the judge
suspended Oakley's 11 year sentence, but imposed a prohibition on Mr. Oakley's right to procre-
ate absent a showing that he could support his children both present and future. On appeal the
prohibition was upheld by the Wisconsin Supreme Court. State v. Oakley, 629 N.W.2d 200
(Wis. 2001). But cf., Trammell v. State, 751 N.E.2d 283 (Ind. Ct. App. 2001). In this case a trial
court included a prohibition on Kristie Trammell's becoming pregnant. She had been convicted
of child neglect on two separate occasions and one instance had resulted in her child's death.
This provision was struck down by the Indiana Court of Appeals.
173. See Roberts, supra note 11, at 94-95 and 304-305.
174. But see Shaw, supra note 137.
175. New combinations of drug treatments have been shown to restore immunity and pro-
long life for infected children and adults. Current treatments have been able to reduce HIV to
undetectable levels in the blood and have allowed for recovery of the damaged thymus, which
plays a key role in developing the immune system. See http://www.healthcare.ucla.edu/vital-
signs/. A combination of AZT, 3TC and efavirenz has recently (2004) been shown to be effective
in reducing viral loads and increasing CD4 cell counts in patients recently infected with HIV
available at http://www.aidsmap.com/en/docs.
176. Carole Ulanowsky & Brenda Almond, HIV and Pregnancy, in AIDS-A MORAL IS-
SUE: THE ETHICAL LEGAL AND SOCIAL ASPECTS 46 (Brenda Almond ed., 1990).
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PART IV: CONCLUSION AND RECOMMENDATIONS
I agree with Dr. Ronald Bayer that if we are to test pregnant wo-
men for HIV, it must be done in a manner that will "empower [them]
to make informed choices on their own behalf according to their own
private values." '177 In 1999, 85 percent of HIV positive pregnant wo-
men received prenatal care.17s Of the 90 percent of pregnant women
offered AZT prophylaxis, 90 percent were compliant. 179 These num-
bers would seem to militate against coercive intervention. If the state
is to intervene in these cases, over the mother's objection, the burden
for intervening should be extremely high. We are talking of interven-
tions of Constitutional dimensions. The State must show a compelling
state interest and the remedy should be narrowly tailored. I would
suggest a course of conduct that incorporates the following
recommendations:
1. Provide adequate, culturally sensitive treatment for substance de-
pendent pregnant women. This would necessarily entail providing in-
patient care where women and their children could be accommodated.
2. Given that outpatient treatment is substantially less expensive,
where appropriate, outpatient care should be developed that speaks to
the specific needs of women. Outpatient treatment has the added ad-
vantage of allowing the mother to maintain relationships with family,
friends and external support systems.
3. Identify specific economic, social and emotional barriers to develop-
ing these recovery/treatment programs for women.
4. Address the harm caused when the substance dependent pregnant
woman is treated using a penal model, rather than a therapeutic
model. Addiction has historically been recognized as an illness rather
than a crime. The needs of society are not served by incarceration.
Moreover, in terms of pure economics, it is much more cost effective
to provide treatment for a woman than to imprison her.
5. Provide integrated care for HIV/AIDS and substance dependent
pregnant women. Women who use drugs during pregnancy, while
small in number, are still the least likely to seek prenatal care. This
will only be exacerbated by threats of imprisonment. There must be
efforts at all levels (federal, state, local and community) to integrate
treatment and prevention services.
6. Develop a system of universal, routine prenatal HIV screening for
pregnant women with both notification and counseling provisions. Al-
177. Ronald Bayer, "Perinatal Transmission of HIV Infection: The Ethics of Prevention," in
AIDS AND THE HEALTH CARE SYSTEM 63, 68 (Lawrence 0. Gostin ed., 1990).
178. See supra note 117.
179. Id.
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though routine screening has traditionally not included a counseling
component, given the nature of the disease and the interventions that
are available to reduce vertical transmission, counseling would be pro-
ductive. I would recommend an opt-out approach under which a wo-
man would be tested unless she declined, but she would have the right
to decline. Universal screening would allow a woman to learn her HIV
status early in her pregnancy (to the extent that we can facilitate early
prenatal care). Voluntary screening and counseling would provide a
pregnant woman with the information she needs to make informed
choices concerning treatment and future child bearing.
7. Identify public and private sector dollars to support treatment and
prevention efforts.
8. Be cognizant of the unique challenges presented in developing
countries. Even a truncated course of treatment might prove to be
cost prohibitive. Relevant drug companies will have to continue with
cost reductions and even then the cost may have to be supplemented
with funds from more affluent countries. Women identified as HIV
positive should be encouraged to bottle feed their infants and ade-
quate breast milk substitutes should be provided.
9. Identify and raise additional funds for research. Much of the pro-
gress that has been made in reducing vertical transmission rates has
resulted from clinical trials. Current research for a vaccine would be a
part of this equation. Ultimately success will not be possible without
commitment and dollars.
10. Be honest about recognizing the role that race and class play in
this pandemic and our response to it.
Careful routine testing and counseling of pregnant women would be
prudent given that half of HIV positive women do not know their
status.180 As indicated above, studies show that the overwhelming ma-
jority of women would accept treatment where it is offered and that if
they are pregnant they would accept treatment on behalf of their
fetus. 181
Our response should not be paternalistic. Testing should be consis-
tent with the CDC recommendations. 82 Programs that work 8 3
should be replicated.
Legal recognition of the shared interest of the mother, the commu-
nity and the potential life is essential. As we develop public policy in
180. Maria J. Brickman, HIV Testing is Urged in Every Pregnancy: Early Warning Can
Sharply Cut Risk of Transmission to Baby, CDC says Counseling is Critical: Fifty Percent of
Infected Women Don't Know it, A Doctor Says, ATLANTA CONST., July 7, 1995, at A3.
181. See supra note 117.
182. See supra note 123.
183. See supra note 67.
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this area, our approach should be wholistic and should cross disci-
plines. Prevention and thoughtful education are paramount. Other
disciplines such as public health and social work must address these
issues because neither the law nor medicine can do it alone. Moreo-
ver, the legal system is probably the least equipped to address these
issues.18 4 Care must be taken not to pit mother against child, a choice
under which we all lose.
184. See Cole, supra note 52.
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